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ABSTRACT 
 
IMPROVING RESEARCH PARTICIPANTS’ UNDERSTANDING 
OF INFORMED CONSENT 
 
by 
 
Debra J. Gillespie  
 
 
The University of Wisconsin-Milwaukee, 2017 
Under the Supervision of Professor Rachel Schiffman  
 
Twenty-five to sixty percent of research participants are unable to understand important 
information during the research consenting process. This lack of comprehension may 
unintentionally expose research participants to potential harm. The purpose of this study was to 
test the teach back method of communication as an intervention to improve research participants’ 
understanding of informed consent. The Shannon Weaver Communication model was the 
theoretical framework supporting this study. The pre-intervention sample (control group) of 18 
participants enrolled in a cardiology clinical trial at a large tertiary hospital in New England 
completed the Quality of Informed Consent (QuIC) survey. Two cardiology research 
coordinators were trained in teach back communication as the intervention. A post-intervention 
sample (experimental group) of 5 participants completed the QuIC survey.  
There was no significant difference in mean scores of objective understanding between 
the pre-intervention and post intervention groups. There was also no significant difference in the 
relationship between objective and subjective understanding in the pre-intervention group 
compared to the post intervention group. There was poor understanding of compensation for 
research-related injury where 50% of the pre-intervention group and 60% of the post intervention 
group were either unsure or answered questions related to this concept incorrectly. 
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Another poorly understood concept was with a description of the procedures to be 
followed. Sixty-one percent in the pre-intervention and no one in the post intervention group 
understood this concept. A Chi-square test for independence indicated no significant association 
between highest educational level obtained and understanding of compensation for research-
related injury or an understanding of procedures to follow. 
With the uncovering of a poor understanding of the two concepts of compensation for 
research-related injury and procedures to follow, not reported in the literature, more research 
specifically targeting these concepts and participants’ understanding are warranted. Inductive 
and deductive approaches may yield interesting results. Institutional and national policies need to 
be put into place assuring participant understanding of all regulatory requirements. However, the 
practical application of such policies cannot be mandated until there is comprehensive science 
available to support its practice. 
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CHAPTER 1 STATEMENT OF PROBLEM 
 
According to the Institute of Medicine (IOM) more than 177,000 registered research 
studies involving human participants are currently taking place in 187 countries representing a 
small portion of ongoing clinical research worldwide (IOM, 2013). With every clinical trial there 
are inherent risks about which every individual needs to be informed before making a decision as 
to whether or not to participate. There is a body of knowledge demonstrating that research 
participants have significant misunderstandings about the potential benefits, risks and other 
aspects of their research study (Barrett, 2005; Bergenmar, Molin, Wilking, & Brandberg, 2008; 
Flory & Emanuel, 2004; Hietanen, Aro, Holli, Schreck, Peura, & Joensuu, 2007; Jefford et al., 
2010; Joffe, Cook, Cleary, Clark, & Weeks, 2001; Meade, 1999; Palmer & Trott, 2013; Paris et 
al., 2007; Schwartz & Appelbaum, 2008). As many as 25-60% of research participants are 
inadequately informed and/or are unable to recall or understand important information during the 
research consenting process (Aaronson, et al., 1996; McCarthy, Waite, Curtis, Engel, Baker & 
Wolf, 2012). If research participants agree to enroll into a research study without truly 
understanding all aspects of the study they might unintentionally be exposed to potential harm 
The purpose of this study was to empirically test the teach back method of communication in 
research participants as a method to improve objective understanding of informed consent. 
Informed Consent for Research 
 
Obtaining informed consent for research is not just the signing of a document, but rather 
a process of developing a relationship between the investigator or member of the research team 
and the potential research participant, in order to provide the participant with the full and 
complete information needed to make a voluntary informed decision including time to have 
questions about the research study answered. Research studies may expose participants to risks 
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or burdens they would not normally face. It is therefore imperative that potential research 
participants be knowledgeable about these risks and burdens through the informed consent 
process (Wendler & Grady, 2008). Clear communication and an assessment of participant 
understanding are a critical part of the relationship between the investigator and the potential 
research participant. Informed consent can be said to have been given by a participant once the 
participant has acknowledged they have a clear appreciation and understanding of the facts, 
implications, and future consequences of an action.  
Background 
In 1932 the United States Public Health Service began a research study to investigate the 
clinical course and progression of syphilis. Black, African American men living in Alabama 
were recruited to participate by the offer of free medical care. The majority of the men recruited 
by the investigators were sons and grandsons of slaves, impoverished and had never seen a 
doctor or received medical care. Thus, the men showed up in hordes. While being screened for 
the study’s inclusion criteria of having venereal disease, the research physicians never disclosed 
to the participants they had syphilis. As physicians studied the natural progression of syphilis, for 
further enticements, families were offered fifty dollars towards burial insurance. With the new 
discovery of penicillin as a powerful treatment for syphilis, the treatment was withheld to the 
research subjects in order for the physicians to monitor the diseases progression. The researchers 
justified the lack of treatment by explaining that these men would not normally be receiving 
medical care, so why miss the opportunity to study the natural progression of the disease. The 
study was originally designed to last 6 months, but continued to enroll and monitor syphilis 
stricken men for forty years. The study came to an abrupt halt in 1972 when it became public 
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knowledge after one of the former venereal disease investigators disclosed to a reporter the 
unethical conduct of the study (Thomas, 2000). 
An institution on Staten Island, New York, named Willowbrook served the mentally 
retarded population from 1947-1987. A research study, partly funded by the United States 
Armed Forces, Department of Epidemiology, was undertaken in 1955 to study the progression of 
and treatment of hepatitis. Children living at Willowbrook were purposely fed fecal matter 
extract and given doses of the live hepatitis virus. Although parental consent was obtained, the 
investigators did not disclose to parents the risks of participation (Robinson & Unruh, 2008). 
Investigators had discovered high rates of hepatitis among the residents at Willowbrook and 
hypothesized that if children were deliberately given an injection of live hepatitis viral strain, 
they would develop immunity. The hepatitis experiments at Willowbrook are commonly cited as 
one of the most serious ethical breaches since the Nazi human experimentations of World War II 
(Robinson & Unruh, 2008). 
In response to the travesties of the Nazi human experimentations during World War II, 
and the unethical conduct of research involving human subjects from the Tuskegee Study, and 
the Hepatitis study at Willowbrook, the National Commission for the Protection of Human 
Subjects of Biomedical and Behavioral Research published a landmark report, “Ethical 
Principles and Guidelines for the Protection of Human Subjects for Research” commonly 
referred to as the Belmont Report (National Commission for Protection of Human Subjects of 
Biomedical and Behavioral Research, 1979). Contained within the Belmont Report are three 
ethical principles guiding research conduct with human participants. These principles include 
respect for persons, beneficence and justice. The focus of this paper is the principle of respect for 
persons, which honors individuals’ right to choice and emphasizes potential research participants 
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must have the capacity to consent as well as comprehend any risks and benefits (Shuster, 1997). 
Working within this principle, investigators are required to provide a consent process to potential 
research participants with sufficient knowledge and understanding of research for informed 
decision making (Whitney, 2001). 
It is common for research consent forms to contain structured and technical language to 
disclose participants’ rights and responsibilities (Institute of Medicine, 2004). The practice has 
been that informed consent documents are typically written at the same reading level as papers 
written for medical journals (Green, Duncan, Barnes, & Oberklaid, 2003). In addition, the 
informed consent process is often seen as “bureaucratic form filling” rather than an important 
and necessary part of the research process requiring time, insight and communication skills 
(Banner & Zimmer, 2012). Institutional Review Boards (IRB) often provide investigators with 
templates for writing informed consent documents that satisfy the IRB’s requirements but do not 
take into account the specific verbiage needed for the study’s population. 
For research participants to give informed consent, four conditions must be met: 
disclosure, comprehension, capacity to understand and voluntary nature (Iltis, 2006). For 
complete disclosure investigators must provide potential participants with sufficient information 
regarding the nature and purpose of the study, the risks and benefits, alternatives, costs and 
protection of confidentiality. Comprehension refers to the language used in the informed consent 
document and must be at a level potential research participants can understand. Capacity to 
understand refers to research participants being legally competent and able to appreciate the 
information given to them and finally, participation in research must be voluntary in nature with 
the option of declining to participate while not jeopardizing their clinical care or right to other 
resources (Iltis, 2006). 
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The essential elements of informed consent are defined in the United States Department 
of Health and Human Service’s Code of Federal Regulations (CFR) and include: the purpose of 
the research, risks and benefits of participation, voluntary nature of participation, a distinction 
between research and clinical care, potential for compensation for a research-related injury, the 
opportunity to ask questions and alternatives to participation (Office of Human Research 
Protection, 2009). The CFR’s has recently been revised and several sections on informed consent 
have been updated specifically in regards to “new requirements relating to the content, 
organization and presentation of information included in the consent form to facilitate a 
prospective subject’s decision about whether to participate in research…” (Federal Register, 
2017, p. 7210). The impetus for these changes came from arguments stating that consent forms 
have evolved over time to be documents more designed to protect institutions from liability 
rather than provide individuals with decision-making information, along with the growing length 
and complexity of these forms making reading and comprehension difficult (Beardsley, Jefford, 
& Mileshkin, 2007; Federal Register, 2017). These new regulations take effect January 2018 so 
it remains to be seen what if any effect there will be to participants’ understanding as a result.  
Obtaining informed consent for research is essential for ethical conduct and a 
requirement of these federal regulations (Flory & Emanuel, 2004). To make the consent process 
truly informed, participants must be given sufficient, understandable information to allow 
independent decision making (Lansimies-Antikainen, Pietila, Laitinen, Schwab, Rauramaa, & 
Lansimies, 2007). This honors individuals’ autonomy and protects them from potential harm 
(Antoniou, Draper, Reed, Burls, Southwood, & Zeegers, 2011). Research participants’ signing of 
a consent form serves as documentation of their consent and voluntary participation and satisfies 
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legal and ethical requirements (Armstrong, Dixon-Woods, Thomas, Rush, & Tarrant, 2012; 
Banner & Zimmer, 2012). 
In 2007 the Food and Drug Administration (FDA) Amendment Act mandated the 
registration of human subjects’ research involving drugs and/or medical devices approved for use 
in the United States (Califf, Filerman, Murray, & Rosenblatt, 2012). The National Institute of 
Health (NIH) developed the database (clincialtrials.gov) for the registration. Each week more 
than 330 research studies are registered on the database, which is the repository for more than 
177,000 studies (Califf et al., 2012). The Clinical Trials Cooperative Group, which is sponsored 
by the National Cancer Institute (NCI) registers more than 25,000 research participants every 
year from more than 3,100 organizations which include more than 14,000 research investigators 
in the United States, Canada, and Europe (National Cancer Institute, 2009). Given the large 
volume of research studies currently being conducted, and the plethora of research demonstrating 
participants’ lack of understanding of informed consent for research, it is imperative that 
interventions to address the issue of respect for persons, including improving comprehension of 
informed consent be addressed. 
Problem Statement 
Clear communication is an important element of healthcare quality and patient safety 
(Institute of Medicine, 2001), yet 47% of Americans, roughly, 90 million, have difficulties 
understanding health information given to them by their providers (Wilson, 2009). It has been 
documented that patients absorb and recall only about half of what physicians have 
communicated to them (Schillinger et al., 2003). In addition, approximately 40-80% of medical 
information is forgotten almost immediately with the greater the amount of information being 
given proportional to the amount of information forgotten (Kessels, 2003). Adding to these 
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alarming statistics is the difficult readability of informed consent documents, particularly 
documents for research participation. Readability is described as the person’s ability to read and 
understand written material (Redish & Selzer, 1985). A document’s readability is determined by 
a mathematical formula applied to written texts in order to predict how difficult the material will 
be for any group to read and understand. This is determined by counting the number of syllables 
per word and number of words per sentence (Buccini, Iverson, Caputi, & Jones, 2010). 
Readability scores are expressed as a grade level equivalent to the number of years of formal 
Western education. Nearly half of American adults read at or below an 8th grade reading level 
(National Center for Education Statistics, 2003). However, most informed consent documents are 
written at a 10th grade reading level or higher (Pfizer, 2014). Written materials for research 
participants must explain complex ideas and information, including the purpose of the study, in 
depth study procedures, and confusing privacy laws.  
Buccini et al. (2010) evaluated the readability of research consents for Human 
Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) and Type 2 
Diabetes research. Ten consent forms from each group were assessed for readability using the 
Simple Measure of Gobbledygook (SMOG) and Gunning Fog Index (FOG). Both the SMOG 
and the FOG are calculated from a free online readability calculator which records readability 
from grade 4 up to grade 18 (post graduate education). Readability scores for both groups of 
documents ranged from a grade level of 9.4 to 16.6. The mean reading grade level for the 
HIV/AIDS consent document was 14.0 and the mean level for the Type 2 Diabetes document 
was 13.3. The authors recognize this does not meet the local ethics committee’s 
recommendations for an 8th grade reading level for research consent documents.  
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Hopper, TenHave, and Hartzel (1995) also assessed consent documents used for 
radiology research. The authors evaluated 284 consent forms from 156 different institutions. The 
sample was taken from active members of the Association of University Radiologists. The 
authors used a computerized software program, Right Writer 4.0, to analyze readability based on 
the year of education, with a readability index of less than 6 considered simple, a readability of 
6-10 considered a good document and more than 10 indicating a complex document. The mean 
readability score for the consent forms was 12 with a range of 8-17. The authors recognized that 
the readability of research consent forms used in radiology were too complex for the average 
person to comprehend. Sharp (2004) and Ogloff and Otto (1991) found similar results when 
assessing consent documents for psychology and oncology research. These studies are also 
supported by LoVerda, Prochazka, and Byyny (1989) who evaluated research consent documents 
used at the Veterans Administration Medical Center, where the authors found that the average 
reading level was 13. 4 and 22% of all text passages were at the post-graduate level. Grossman, 
Piantadosi, and Covahey (1994) and Cheung, Pond, Heslegrave, Enright, Potanina, & Siu (2010) 
found similar results with oncology research consent forms. Beardsley et al., (2007) show that in 
recent years, the average number of pages in oncology research consent forms has increased 
from 7 to 11. In addition, in oncology research, very long (20 letter) words are expected to be 
read and understood by participants who may have recently received a devastating diagnosis, and 
are in a fragile state of mind contributing to the difficulties of their understanding (Griffith, 
Wright, Hackworth, & Gilheart, 2012). Terminally ill patients may be eager to enroll into a 
research study believing it their last chance for a “cure” and thus negate the potential for risks. 
Of particular consideration to investigators is the fact that people with chronic mental and/or 
physical health conditions are among several vulnerable populations whose reading level is 
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below the 8th grade national average (Plain Language and Action Information Network, 2014). 
Given what is currently known about the length and complexity of the language used in research 
consent forms, it is important for investigators to assign enough time to adequately discuss all the 
elements within the consent form and to assess potential research participants’ understanding 
during the consenting process. Kemp, Floyd, McCord-Duncan, & Lang (2008) believe that 
asking simple yes/no questions is not adequate to assess understanding. The authors’ state there 
may be times when patients did not understand instructions well enough to formulate a question 
and therefore simply respond “no” when asked if they have any questions (Kemp et al., 2008). 
Despite the plethora of research on patients’ misunderstanding of medical information, 
physicians still do not routinely check for understanding during clinical encounters with patients 
(Kemp et al., 2008). The potential for harm may increase significantly when enrolling into a 
research study without fully understanding the risks. 
Despite 25 years of research describing the problem with informed consent processes, 
empirical evidence testing interventions to improve communication and participant 
understanding during the informed consent process have primarily been conducted with 
Oncology patients. This may be due to the potential high risk to participants when testing new 
cancer treating pharmaceuticals as well as initiatives from the National Cancer Institute (NCI) 
for improving informed consent for research participants (National Cancer Institute, 2009). Other 
studies have tested interventions at improving informed consent understanding among HIV 
patients, healthy volunteers or asthmatic patients (Coletti, Heagerty, Sheon, Gross, Koblin, 
Metzger, & Seage, 2003; Dresden & Levitt, 2001; Paris et al., 2007; Sengupta, Lo, Strauss, Eron, 
& Gifford, 2011; Stunkel et al., 2010). Only a few studies were found that enrolled Cardiology 
patients (Bjorn, Rossel & Holm, 1999; Kripalani, Bengtzen, Henderson & Jacobson, 2008). All 
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of these studies have mixed results or lack a theoretical framework. Given the potential risks 
involved in research participation, it is imperative that interventions to improve the research 
consenting process be empirically tested, thereby enhancing communication, participant 
understanding and ensuring true voluntary participation. 
With increasingly complex and sophisticated research protocols, high-risk treatment 
options, an aging population at risk of cognitive impairment and an increased awareness of the 
overwhelming problem of low health literacy, there is an urgent need to ensure that participants 
truly understand all aspects of their research study prior to consenting. To make sure that 
research participants are truly informed, information must be communicated in a manner they 
can understand (Lansimies-Antikainen et al., 2007). One place to start would be to look toward 
communication theories as a possible framework to guide studies specifically testing 
interventions to improve research participants’ understanding of informed consent. 
The overarching concept of this dissertation is communication as it pertains to informed 
consent for research. Although the current state of the science informs us of participants’ 
misunderstandings of the research study in which they participate, and poor health literacy in this 
country, empirical studies testing specific interventions that influence the degree to which 
participants understand or misunderstand research participation information have limitations. 
Many of the interventions that have been empirically tested have focused on simplifying 
the language in the informed consent document or providing potential research participants with 
other consenting methods such as the use of videos. When conducting an extensive literature 
search on this topic, only one study was found that tested the teach back method of 
communication in this cohort (Kripalani et al., 2008). No studies were guided by a theoretical 
framework. Additionally, the majority of studies testing interventions to improve research 
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participants’ understanding have been conducted with Oncology patients. No studies were found 
that addressed interventions improving understanding for patients enrolled in cardiology clinical 
trials. Therefore, this study will address these gaps in the literature and add to the body of 
science for this potentially vulnerable population. 
Theoretical Framework 
 
Communication is a complex behavior, combining physical and mental events, with the 
aim of exchanging messages between two or more individuals (Schindler, Ruoppolo, & Barillari, 
2010). The field of communication is very broad and encompasses many forms of 
communication from interpersonal communication to public broadcasting to the masses, to 
speech and language development. Communication theory may be used to understand, explain 
and predict health beliefs, attitudes, intentions, and behaviors of individuals, dyads, or groups 
(Bylund, Peterson, & Cameron, 2012). “An interesting and novel focus for improving consent 
could be creating interventions designed explicitly on improving communication skills” 
(Nishimura, Carey, Erwin, Tilburt, Murad, & McCormick, 2013, p. 12). The following section 
will describe the communication model used to support this research. 
Shannon Weaver Model of Communication 
 
The Shannon Weaver model of communication (Figure 1) was first developed in 1948 
by engineers from Bell Laboratories who felt the need to develop a framework around signal 
transmissions with telephone line capacities and distortions. Weaver then extended the 
framework to other kinds of communication and developed the philosophical aspects of the 
framework as it applies to communication in general (Shannon & Weaver, 1948). The Shannon 
Weaver model contains the following elements required for communication: information source 
(sender), transmitter (encoder), channel, reception (decoder), and the destination (receiver). The 
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sender is the person who starts the conversation with a message he/she wishes to convey. The 
sender encodes the concept of what he/she wants to communicate by putting it into an 
understandable format for the receiver to be able to interpret. Decoding occurs by the receiver as 
he/she interprets the message. The message is the idea or concept with a distinct meaning. The 
channel is the route the message is sent and can be verbal or written, on paper, or electronic. The 
authors further explain that the communication or message is effected by noise that may occur 
within the channel. Level A noise is referred to as any interference or distortion that may lead to 
changes in the initial message such as the static one hears on the telephone line or the physical 
noise in the room. Level B noise is the semantic noise such as the vocabulary the source has 
chosen to use that may potentially contribute to misunderstanding of the message. The 
vocabulary used by the sender is problematic when it contains medical terminology that the 
receiver may not understand. This “noise” leads to misunderstanding of the message. Shannon 
and Weaver (1948) state that in order for communication to be clear, the noise must be reduced. 
The next step in the model is the feedback loop. This is where the sender asks the receiver to 
state back in their own words what they heard as the message. If the message is inaccurate the 
sender has the opportunity to provide clarification of any miscommunication and an opportunity 
for the sender and receiver to ask questions as necessary. 
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Figure 1. Shannon-Weaver Communication Model 
The Shannon Weaver Model of Communication was applied to empirically test the 
communication intervention of “teach back” to determine whether or not this communication 
method improved research participants’ understanding of the informed consent process, 
including specific required elements of informed consent as required by federal regulations 
(Figure 2). It was hypothesized that the teach back method of communication would improve 
research participants’ understanding of informed consent in the following ways: provide new 
skills to the sender (research coordinator) to encode complex medical and scientific concepts into 
lay language which would decrease the noise by avoiding the over use of medical terminology, 
along a verbal channel during the initial informed consent process. The feedback loop (teach 
back) is where the receiver (potential research participant) states back in his/her own words what 
it is he/she heard/understood the sender to say. By applying the principles of teach back it was 
hypothesized that there would be a reduction of Level B noise thereby leading to an 
improvement of the receiver’s (potential research participant) interpretation and understanding of 
the complex information provided at the time of obtaining informed consent for research. 
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Figure 2. Modified Shannon Weaver Model as Applied to Research Consenting 
  
 Interpersonal communication is a key component of the research investigator and 
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described as when the patient is asked to state back in their own words, to the educator, what 
they have learned (Negarandeh, Mahmoodi, Noktehdan, Heshmat, & Shakibazadeh, 2012). 
Teach back was developed to allow the educator to determine if the communicated message was 
received correctly, thus allowing for the message to be tailored to each individual’s literacy level. 
This relatively simple and quick method allows the educator to evaluate the patient’s level of 
understanding. Teach-back has demonstrated increased patient comprehension leading to 
improvements in clinical outcomes (Kornburger, Gibson, Sandowski, Maletta, & Klingbeil, 
2013; Negarandeha, et al., 2012). Yet this simple communication strategy has not been widely 
tested as a method of communication when obtaining informed consent for research 
participation. 
In a study by Kemp et al., (2008) patients viewed three physician-patient scenarios of 
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(teach back) method for inquiring about patient understanding of new medical information. The 
yes/no method was used as it is frequently applied in practice and allows for only closed-ended 
responses when patients are asked if they understand their instructions. The Tell-back Directive 
used an authoritative, paternalistic approach to assessing patient understanding and the Tell-back 
Collaborative approach asked patients to tell back in their own words what the physician had 
said in order for the physician to assess his/her own communication. This method creates an 
environment where patients do not need to feel embarrassed if they do not understand their 
instructions and is the recommended approach (Weiss, 2003). The Tell-back Collaborative 
method was preferred by patients when compared to the Tell-back Directive and the yes/no 
method (Kemp et al., 2008).  
 Nishimura et al. (2013) conducted a meta-analysis of randomized clinical trials testing 
interventions to improve participant understanding of informed consent for research. The meta-
analysis was conducted on 22 interventions which included the use of multi-media, enhancing 
the informed consent document and extended discussion. There were no significant increase in 
participants’ understanding with the use of multi-media, but there were significant increases in 
understanding among research participants when alterations were made to the informed consent 
document (shorter and lower reading level) and having an extended discussion. The authors 
concluded that when using extended discussion approaches there was an increase in participants’ 
understanding when compared with a controlled consent discussion and state there is no 
substitute for personal communication where there is the opportunity for questions and answers 
(Nishimura et al., 2013). Dunn and Jeste (2001) had similar conclusions from their systematic 
review of participants’ understanding of informed consent for research and state one effective 
intervention is that of corrected feedback. “Learning to develop communication skills to obtain 
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feedback and verify successful communication is critical to working competently with others, 
and contributes to addressing the problem of health literacy” (Institute of Medicine, 2004, 
p.118). These systematic reviews as well as the IOM’s report suggest the teach back process of 
communication may be one possible intervention to improve research participants’ 
understanding. Given the plethora of research demonstrating research participants’ 
misconceptions during and after the informed consent process, more studies examining the 
communication between the investigator and the potential research participant are needed.  
Purpose 
The purpose of the current study was to empirically test the teach back process of 
communication when obtaining informed consent for research participation. 
Research Questions and Hypotheses 
The research questions for this study were expressed using the Patient, Intervention, 
Comparison, and Outcome (PICO) method (Stillwell, Fineout-Overholt, Melnyk, & Williamson, 
2010). The research questions driving this study were 1. In research participants, will the use of 
the teach back process of communication compared to standard language, improve objective 
understanding of informed consent? 2. In research participants, is the relationship between 
objective and subjective understanding different in the control group (standard communication) 
compared to the experimental group (teach back communication)?  
The following hypotheses were proposed for testing in this study: participants will have a 
greater understanding of the risks, benefits and other key elements of their research study after 
receiving the teach back process of communication. A secondary hypothesis is that there will be 
less of a difference between objective and subjective understanding within the experimental 
group.  
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Independent and Dependent Variables 
 The independent variable was the teach back process of communication (the 
intervention) and the dependent variables were participants’ objective and subjective 
understanding as measured by scores on the Quality of Informed Consent (QuIC) Instrument 
developed by Joffe, Cook, Cleary, Clark and Weeks (2001). 
Significance to Nursing 
According to Carper (1978) a profession will determine the kind of knowledge it aims to 
develop by organized, tested and applied means. Carper (1978) challenges the nursing profession 
to develop an empirical body of knowledge specific to nursing yet this scientific quest has been 
slow. Knowledge and the scientific foundation of any profession is developed using strict 
methodological rigor involving the conduct of human subjects’ research. Traditionally, clinical 
nurses have had very little involvement in nursing research. While an introductory course in 
research may be offered at the Baccalaureate educational level, once graduated, those research 
concepts have not been applied to practice. Nurses’ involvement with research has evolved over 
the past thirty years as the profession has undergone a paradigm shift from technical and task 
oriented to a more autonomous, science-based profession (Smirnoff, Ramariz, Kooplimae, 
Gibney, & McEvoy, 2007). With this shift has come an expectation that the nursing profession, 
including clinical nurses will embark upon scientific inquiry to define its practice. 
In recent years the evidence-based practice (EBP) paradigm has gained momentum 
within the nursing profession with clinicians and administrators embracing EBP to make practice 
changes for improvements in patient outcomes. With the EBP paradigm comes the expectation 
that clinical nurses will lead practice changes. This requires the ability to not only be an evidence 
consumer, but an evidence creator as well. When there is an area of clinical practice that does 
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not have an evidence base, nurses, with appropriate preparation and guidance from doctorally 
prepared nurses need to design and conduct research studies. Bedside clinicians conducting 
research is a relatively new phenomenon with many nurses not having the specific knowledge 
and skill set. Additionally, nurses working in the role of research coordinator have little formal 
education and training for that role, yet are often required to obtain informed consent from 
potential research participants. Particularly important is the knowledge of regulatory 
requirements when obtaining informed consent for research as well as the roles and 
responsibilities of the Principal Investigator.  
 Although there is a plethora of research studies addressing the issue of poor 
comprehension among research participants, few studies have been published in nursing 
journals, those typically read by nurses. Additionally, many recently published books on the 
conduct of nursing research do not address the regulatory requirements and other issues for 
obtaining informed consent for research participation. 
Although there are many research translation models currently adopted by organizations 
none specifically address how to enroll participants into a research study. Informed consent and 
the communication skills needed to obtain and assess participant understanding are currently not 
a part of the national nursing dialogue. 
 In 1994 the American Nurses Association (ANA) published a position statement, 
Education for Participation in Nursing Research which outlines nurses’ involvement in the 
conduct of research from the Associate degree through the Doctoral degree educational level. 
Although the Associate Degree prepared nurse may be involved in research by identifying 
clinical issues and data collection, it is at the Baccalaureate educational level where the ANA 
describes nurses’ involvement with human subject and potential research participation. “Ethical 
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principles are a big part of the baccalaureate education, not the least of which is the protection of 
human subjects” (American Nurses Association, 1994). 
The American Nurses Credentialing Center’s (ANCC) Magnet Recognition Program 
requires hospitals to document how clinical nurses are evaluating and incorporating research into 
their professional practice. ANCC also expects clinical nurses to take the lead on process 
improvement changes and to disseminate results internally and externally (Weierbach, Glick, 
Fletcher, Rowlands, & Lyder, 2010).  
This paradigm shift in nursing practice will require doctorally prepared nurse scientists 
working in the clinical arena to serve as research mentors to clinical nurses. According to 
Aaronson et al. (1996) “remarkably little attention has been paid to the potential contribution of 
nurses to the informed consent process” (p 985). Given the amount of time nurses spend with 
patients, both in the inpatient and outpatient settings, and their role in education, nurses are better 
positioned to provide and reinforce information patients have heard during the informed consent 
process. In order to be able to assist with this education and clarify any misunderstandings 
research participants may have, nurses need the knowledge of the federally mandated consent 
required in each research consent document. 
Although one may agree clinical nurses’ involvement in evidence-based practice a good 
thing, obtaining informed consent from potential research participants takes an additional skill 
set not traditionally provided in primary nursing education. Doctorally prepared nurse scientists 
have the analytic abilities to design research studies around clinical questions and the knowledge 
of regulatory requirements when conducting research. As more and more hospitals are seeking 
ANCC’s Magnet recognition, with its research requirements, more and more hospitals are hiring 
doctorally prepared nurses to serve as mentors to staff. When these nurse scientists conduct their 
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own research studies and/or are mentoring others they must incorporate these best practices 
when obtaining informed consent. 
Finally, this study will advance the science on what is currently known about teach back, 
empirically test the teach back communication process in the understudied cohort of Cardiology 
research participants and test the use of the Shannon Weaver Communication Theory. 
Breakdown in communication most often occurs during the decoding of the message by the 
receiver (Odell, 1996). Schramm (1954) points out that the more commonalities there are 
between the sender and the receiver the more likely the chance of the message being interpreted 
as intended. One way to enhance the commonalities is to avoid the use of medical terminology 
and jargon. Decreasing the use of medical terminology is one of the steps in the teach back 
training process. 
Chapter Summary 
 Meade (1999) recognized the absence of underlying theoretical frameworks supporting 
empirical research on informed consent and suggests scholars look towards the discipline of 
communication. Despite the plethora of research on participants’ understanding of informed 
consent, most studies do not propose a specific theory for conducting or improving the informed 
consent process (Sankar, 2004). According to Conn, Rantz, Wipke-Tevis, & Maas (2001) an 
intervention is more likely to be effective if based on a model or theory and in particular reflect 
key constructs within the conceptual framework. Without relating the intervention to a theory or 
framework, the results are likely to be misinterpreted. Furthermore, innovative communication 
interventions need to be developed and tested to assist informed consent for research (Meade, 
1999). This research study will add to the body of the science by incorporating a communication 
theoretical framework. 
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Structure to Dissertation 
 This dissertation is organized in the following manner: Chapter 1 provided a brief 
overview of the topic. Chapter 2 is divided into Parts A and B and includes two manuscripts. Part 
A is a critique of the theoretical framework supporting this dissertation and Part B is a systematic 
review of the literature to describe the current state of the science. In Chapter 3 the research 
methods including design, sample, research questions, hypotheses, intervention and data analyses 
are described. Chapter 4 presents the results of this study and includes the third manuscript. In 
Chapter 5 the study is summarized, limitations addressed and a discussion of implications for 
nursing, policy and future research are provided.  
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CHAPTER 2 REVIEW OF LITERATURE 
This chapter consists of two manuscripts. The first manuscript is a critique of the 
Shannon Weaver Communication theory. The second manuscript is a systematic review of the 
literature.  
Teach Back has been published by the Joint Commission as one of its top patient safety 
goals (The Joint Commission, 2007). The National Quality Forum also endorses teach back as 
part of best practice (Wu, Nishimi, Page-Lopez, & Kizer, 2005). Additionally, teach back is a 
requirement for the American Nurses Credentialing Center’s (ANCC) Magnet Recognition 
program. This has led to teach back being implemented in many healthcare organizations. With 
more and more hospitals implementing teach back and more literature being published on its 
empirical use, an article critiquing a communication theory to support teach back is timely. The 
Journal Research and Theory for Nursing Practice was chosen as the journal for submission for 
this manuscript. This journal was chosen because it is a peer-reviewed journal that primarily 
publishes knowledge development in a broad sense to include issues relevant to making 
improvements in nursing education and practice. Formatting per the journal’s requirements will 
be completed prior to submission.  
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Abstract 
With the Joint Commission’s revelation that as much as 65-70% of the time 
miscommunication has been discovered to be the root cause of many sentinel events, it may be 
timely to examine a communication theory to support practice improvement efforts. Effective 
communication has been shown to decrease medical errors, improve patient satisfaction, and 
increase adherence to treatment plans leading to better health outcomes yet very few studies have 
examined communication theories and their applicability to practice. This article will examine 
the Shannon Weaver Communication Theory as one theory that may support future studies 
examining the teach back communication method as a means to improving patient health literacy 
leading to improvements in clinical practice.  
Keywords theory, communication, teach back 
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Introduction 
 A theory is a coherent and non-contradictory set of statements, concepts or ideas that 
organizes, predicts and explains phenomena, events, and behavior (Bem & Looren-de-Jong, 
1997). Theories are common in the social sciences such as psychology, sociology and nursing to 
develop an understanding of basic and clinical sciences. “Theoretical thinking in nursing uses 
concepts and their relationships to organize and critique existing knowledge and guide new 
discoveries to advance practice” (Higgins & Moore, 2000 p. 179). A formal method for 
theoretical analysis is important in order to determine if the theory has the potential to be useful 
in the educational, clinical or research arena. By analyzing a theory, the theory’s attributes 
maybe optimized to guide clinical practice. The following six steps of theory analysis as outlined 
by Walker & Avant (2010) were employed as the Shannon Weaver Communication theory 
(Figure 1.) was critiqued: 1. identify the origins of the theory 2. examine the meaning of the 
theory 3. analyze the logical adequacy of the theory 4. determine the usefulness of the theory 5, 
define the degree of generalizability and the parsimony of the theory and 6. determine the 
testability of the theory(Walker & Avant, 2010). 
The Origins of the Shannon Weaver Communication Theory 
In 1947, Shannon, a research mathematician at Bell Laboratories developed a 
communication theory to explain data transmitted over telephone lines. The purpose of the 
theory was to describe signal transmissions with maximum capacity and minimal distortions 
(Shannon & Weaver, 1948). This theory describes technical problems with the accuracy of both 
the signal and the speech being transferred from sender to receiver. The Shannon Weaver model 
was based on information theory to describe the predictability of messages being received 
accurately. Although the theory first described telephone signal transmissions, the original linear 
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model was later adapted to describe the flow of information with a feedback loop from the 
receiver to the sender added to the model to better describe inter-personal communication 
(Shannon & Weaver, 1948). The authors recognize that certain characteristics distort, or change 
the way a message was intended. For example, static on the telephone line or medical 
terminology used by healthcare professionals to lay persons may contribute to the message being 
misinterpreted by the receiver. 
The Shannon Weaver Communication theory is historically significant as it was 
described at the time telephone and computer technologies were being developed post World 
War II. Many people working in the field of human communication had difficulties 
understanding the formulas used in Shannon’s mathematical theory, but the pictorial model is 
easy to understand. The source-channel-receiver diagram quickly became the standard 
description of interpersonal communication during conversations between two people. The 
terminology used in the model is still the basis for the description of interpersonal dialogue 
(Griffin, 1997). 
The Meaning of the Theory 
According to Walker & Avant, (2010) the meaning of the theory refers to its concepts 
and the relationship among them. The Shannon Weaver model contains the following concepts 
required for communication: information source (sender), transmitter (encoder), channel, 
reception (decoder), and the destination (receiver). The sender is the person who starts the 
conversation with a message he/she wishes to convey. The sender encodes the concept of what 
he/she wants to communicate by putting it into an understandable format for the receiver. The 
channel is the route the message is sent and can be verbal or written, on paper, or electronic. 
Decoding occurs by the receiver as he/she interprets the message. The message is the idea or 
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concept with a distinct meaning. The authors further explain that the message may be distorted 
by noise that occurs within the channel. Level A noise is any interference that may lead to 
changes in the initial message such as the static one hears on the telephone line or music playing 
in the room. Level B noise is the semantic noise such as the vocabulary the source has chosen to 
use that may potentially contribute to misunderstanding of the message. For example, the 
vocabulary used by the sender is problematic when it contains medical terminology that the 
receiver may not understand. This “noise” leads to misunderstanding of the message. Shannon 
and Weaver (1948) state that in order for communication to be clear, both level A and level B 
noise need to be reduced. The final step is the feedback loop. It is during the feedback loop that 
the sender asks the receiver to state what he/she heard as the message, provide clarification of 
any miscommunication and an opportunity for the receiver to ask questions. This feedback loop 
takes the model from its original linear conception to reflect what is more consistent of dialogue. 
Frandsen and Millis (1993) recognize the feedback loop has been absent in many other 
communication theories. Schillinger et al. (2003) describe feedback as the “communication 
loop.” 
The Logical Adequacy of the Theory 
To understand the logical adequacy of a theory the analyst must examine the outcomes 
the theory is able to predict. For the Shannon Weaver Communication theory, the concept of 
noise predicts whether or not communicated messages are received as intended. When analyzing 
the theory we need to ask ourselves if the flow of the relationship among the concepts makes 
sense, seems logical and is able to make predictions. When viewing the diagram of the Shannon 
Weaver Communication theory, the reader can quickly assess the relationships among the 
concepts by the use of the arrows denoting messages from the sender, through a communication 
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channel and to the receiver. Likewise, the reader is able to understand by the arrow from the 
receiver back to the sender that this part of the theory explains the concept of feedback. This 
structure is logical and able to make the predictions of communicated messages received both 
accurately and inaccurately, depending upon the level of noise. The model does not predict when  
or where noise will occur, but make suggestions for decreasing the level A and level B noise to 
improve upon the probability of the sender’s message being accurately received. 
The Usefulness of the Theory 
A theory is considered useful if researchers are able to use it to explain phenomenon, 
offers new insights into a phenomenon, and make predictions based upon the theory (Walker & 
Avant, 2010). The theory should identify which clinical issues may support its use, and if the 
theory has the potential to influence practice, education or research (Walker & Avant, 2010). If 
the theory is new then it should make significant contributions to the field in which it was 
developed. The time in history immediately after World War II saw an explosion in information 
technology with further development of the telephone and the television. The Shannon Weaver 
Communication theory first described at this time, made significant contributions that helped 
explain how communication was sent, received and interpreted over telephone lines and was 
later adapted to include a description of interpersonal communication. The Shannon Weaver 
Communication theory is one of the most widely used inter-personal communication models. 
Part of its success is in its ability to explain how communication works, and how communication 
fails (Foulger, 2004).The body of research conducted on healthcare communication has primarily 
focused on physician patient communication, specifically from the perspective of the physician 
giving the patient bad news (Sheldon, Barrett, & Ellington, 2006). For nurses working in a busy 
and complex healthcare environment, communication may often become hurried and medically 
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oriented yet very few studies have focused on the nurse patient communication (Sheldon et al., 
2006). By using a theoretical framework, such as the Shannon Weaver Communication theory, 
more studies may be conducted that might provide insight into the breakdown of communication 
and the introduction of “noise” between the nurse and the patient. 
For many hospitals today, patient satisfaction data are captured by the Hospital Consumer 
Assessment of Healthcare Providers and Systems (HCAHPS) scores and are publicly reported. 
This survey instrument was developed in partnership with the Center for Medicare and Medicaid 
Services (CMS) and the Agency for Healthcare Research and Quality (AHRQ) and endorsed by 
the National Quality Forum (NQF) (hcahpsonline.org, 2014). The public reporting of the 
HCAHPS scores is designed to increase transparency and stimulate hospital incentives to 
improve practices. One of the many questions posed to patients after discharge from the hospital 
are their perceptions of the communication between the nurses and themselves. If scores are low, 
it is difficult for hospitals to create quality improvement processes without first identifying the 
areas of communication failures. Applying a communication theory to practice will help to 
identify areas of “noise” leading to communication failures which may then lead to appropriate 
quality initiatives. 
One major criticism of the Shannon Weaver Communication model is that it was 
originally designed for data transmission which has no meaning attached to it as opposed to 
information sharing where the receiver attached meaning and emotion to the message (Stewart, 
Malayan, & Roberts, 2001). This thought is echoed by Chandler (1994) who believes the model 
reduces communication to the simple transmission of information where information has no 
meaning. Haworth and Savage (1989) point out that the model focuses on the communication 
skills of the sender and does not take into account non-verbal communication thereby ignoring 
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the inferences the receiver may have assumed. Weaver defends this by stating that information 
technologies, such as the telephone lines of communication are no longer simply technical 
devices but are a metaphorical description of language in general (Day, 2000). Finally, Genosko 
(2012) states that this model misses the concept of environment which shapes the senders and 
receivers meanings of messages. 
The Generalizability of the Theory 
The Shannon Weaver Communication theory has greatly contributed to the advancement 
of computer science (Chandler, 1994). The model has been widely adopted by many disciplines 
including psychology, sociology, education, organizational analysis and nursing and is the most 
widely used communication model due in part to its simplicity and generalizability (Chandler, 
1994). According to Walker and Avant (2010) the more far-reaching a theory can be applied the 
more generalizable it is. 
Patient-centered care is defined as "Providing care that is respectful of and responsive to 
individual patient preferences, needs, and values, and ensuring that patient values guide all 
clinical decisions" (Institute of Medicine, 2001). Patient centered care first developed from the 
work of Neuman and Young (1972) has as its core value collaboration with the patient (Hart, 
2010).Collaboration with the patient allows the patient and family to participate in healthcare 
decision making and requires effective communication skills (Hart, 2010). Shared decision 
making by patients and families is encouraged by the Center for Medicare and Medicaid Services 
(CMS) and whose language is included in the Affordable Care Act of 2010 (Lee & Emanuel, 
2013). To achieve shared decision making all healthcare practitioners need to have effective 
communication skills. With medical treatment options comes the decision to determine if 
benefits outweigh any risks. This is particularly important when patients are approached to enroll 
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into a research study that may pose additional risks they would not necessarily be exposed to. 
Excellent communication skills by all healthcare personnel are needed to adequately inform 
potential research participants of these risks and must include the ability for the research 
personnel to assess for participant understanding. The use of the Shannon Weaver 
Communication Theory will allow the investigator and other research personnel the ability to 
transform their intended messages into language for lay persons to understand, assess for 
understanding through the feedback process and increase the likelihood of the message being 
delivered as intended. 
The Testability of the Theory 
For a theory to be considered valid, it must be tested (Walker & Avant, 2010). Nursing 
knowledge development begins with theory testing; yet testing theories has been acknowledged 
as being underutilized in nursing (McQuiston, & Campbell, 1997). “Theoretical thinking in 
nursing uses concepts and their relationships to organize and critique existing knowledge and 
guide new discoveries to advance practice” (Higgins, & Moore, 2000, p. 179). Although the 
quest for nursing knowledge never ends, theoretical models offer an important viewpoint for 
building a better understanding of nursing phenomenon (Carper, 1978). Bylund, Peterson, & 
Cameron (2012) tell us that studies may be grounded with the use of a theory as a starting point 
and additionally may add further explanation to the study’s findings. Many aspects of the 
provider/patient relationship both verbal and nonverbal arise within the healthcare environment. 
Communication theories need to be further tested in the healthcare arena to determine its value 
and applicability and to add to the current state of the science. Although the Shannon Weaver 
Communication Theory was not originally developed to describe interpersonal communication, 
with the addition of the feedback loop, it appropriately describes interpersonal dialogue. To 
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communicate effectively, we need to familiarize ourselves with the issues involved in the 
communication process. Once we are aware of them, these issues will help to plan, analyze 
situations, solve problems, and make process improvements (Lee, 1993). The use of the Shannon 
Weaver theory will allow for this identification and analysis. Where there are untested theoretical 
concepts it is prudent to test those relationships which will add to the body of knowledge 
(Walker & Avant, 2010). 
Significance to Nursing 
Disciplines often share knowledge and borrow theories which continue to be transformed 
as practice environments change (Reed & Shearer, 2011). An important function of nursing 
practice is to communicate to patients and families about their illness and treatment options 
(Kruijver, Kerkstra, Francke, Bensing, & van der Wiel, 2000). Another important 
communication goal is to establish interpersonal relationships with patients in order to exchange 
information, give explanations, and provide physical care (Caris-Verhallen, Kerkstra, & Bensing, 
1997). Peplau described a theory of interpersonal relations between the nurse and the patient by 
describing phases of the developing relationship (Caris-Verhallen, Kerkstra, & Bensing, 1997). 
Although this theory explains the intimate and unique relationships nurses have with patients it 
does not describe the nature or process of communication occurring within the relationship. 
Other nurse theorists have described the nurse patient relationship as one that is dynamic such as 
Orlando’s interaction theory (Orlando, 1961) and King’s interacting systems conceptual 
framework (King, 1981). However, neither of these theories describes how communication is 
channeled, by whom, what process and what happens when communicated messages fail. The 
Shannon Weaver model, born out of technology and communication studies may provide a 
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framework for the intimate messages shared in a bi-directional manner between nurses and 
patients. 
Conclusion 
Critique of a theory highlights the theory’s strengths and limitations, identifies gaps, 
questions existing knowledge and identifies areas for further testing (Silva & Sorrell, 1992). 
Theoretical analysis consists of breaking down all the parts or concepts within the theory to 
determine how they relate to each other. This allows for the examination of the validity of the 
theory for its use in real world situations including need for further refinement (Walker & Avant, 
2010). After analysis is complete the investigators may determine the theory’s potential 
contribution to the discipline of nursing and the advancement of scientific knowledge (Walker 
and Avant, 2010). 
The Joint Commission revealed that miscommunication was the root cause 65-70% of the 
time when analyzing more than 3000 sentinel events from 1995-2005 (Adamski, 2007). Not only 
does effective communication decrease medical errors, it also improves patient satisfaction, and 
better adherence to treatment plans leading to better health outcomes (Fink, Prochazka, & Wu, 
2006). Communication between healthcare professionals facilitates the success of interventions 
by promoting learning and new sense making (Jordan, Lanham, Crabtree, Nutting, Miller, 
Stange, & McDaniel, 2009). In addition to miscommunication leading to medical errors it has 
previously been described how miscommunication leads to lack of understanding of the risks, 
benefits and other critical aspects of a research study. Therefore, communication, how we speak 
to patients, potential research participants, the messages we send, the language we use all impact 
how the received message is interpreted. Employing the feedback loop in the communication 
process has been recommended as an effective method to improve patient understanding of 
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medical information (Sayah, Williams, Pederson, Majumdar, & Johnson, 2014). Assessing for 
patient understanding is a critical element of good communication. The Shannon Weaver 
interpersonal communication theory with its feedback process from the receiver to the sender 
may be a good theoretical framework for further research into empirical studies testing the teach 
back method as interventions with different patient cohorts in different unique settings. 
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Figure 3.Shannon-Weaver Communication Model 
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Manuscript Two: Review of the Literature 
For the second manuscript the Journal of Advanced Nursing was selected for submission 
of a systematic review of the literature on interventions to improve research participants’ 
understanding of informed consent. As more and more hospitals are expecting nurses to become 
involved in research, there is a large learning curve on the regulatory requirements around 
informed consent for research. It is imperative that clinical nurses understand the significance of 
participants’ lack of understanding when consenting to participate in research. Therefore, a 
journal that is primarily published for nurses was chosen. For the purposes of this chapter, APA 
format has been used to be consistent with all other chapters in this dissertation. Formatting, per 
the journals’ requirements will be completed prior to submission.  
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Abstract 
 
 The United States Department of Health and Human Services (DHHS) mandates that 
informed consent information given to potential research participants be in a language and 
reading level understandable to them.  Despite this, it is common for consent forms to contain 
structured and technical language to disclose participants’ rights, and responsibilities often 
written at a college or graduate level. Significant misunderstandings about risks, benefits and 
other aspects of research are misunderstood by as many as 24-74% of participants. The purpose 
of this review is to systematically evaluate single, empirically tested interventions designed at 
improving research participants’ understanding of informed consent. 
Keywords: consent, informed consent, research, clinical trials, research participation, 
research subjects, research understanding, research comprehension and interventions 
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Introduction 
 In 1989 the United States Food and Drug Administration (FDA) joined Japan and the 
European Union (EU) in founding the International Conference on Harmonization (ICH) of 
Technical Requirements for Registration of Pharmaceuticals for Human Use. The purpose of the 
ICH is to standardize the pharmaceutical development procedures when conducting human 
subjects’ research. As part of this effort, the ICH has developed "Good Clinical Practice" (ICH-
GCP) guidelines including requirements for informed consent (Miller, 1997). These guidelines 
clearly state the language used in both oral and written information about the clinical trial, 
including the written informed consent form, should be as non-technical as practical and 
understandable to the subject. (International Conference on Harmonization-Good Clinical 
Practice, 2016). Despite this, it is common for consent forms to contain structured and technical 
language to disclose participants’ rights, and responsibilities. Many studies have demonstrated 
that consent forms are typically written at a college or graduate level, the same level one would 
write for peers rather than lay persons (Buccini, Iverson, Caputi & Jones, 2011; Cheung, Pond, 
Heslegrave, Enright, Potanina & Siu, 2010 ; Green, Duncan, Barnes, & Oberklaid, 2003; 
Institute of Medicine, 2004). It is no wonder that as many as 24-74% of research participants 
have significant misunderstandings about their research (Joffe, Cook, Cleary, Clark, & Weeks, 
2001).  
Several authors have previously conducted systematic reviews on participants’ 
understanding of research consent (Cohn & Larson, 2007; Dunn & Jeste, 2001; Falagas, Korbila, 
Giannopoulou, Kondilis, & Peppas, 2009; Flory & Emanuel, 2004; Montalvo & Larson, 2014; 
Nishimura, Carey, Erwin, Tilburt, Murady & McCormick, 2013; Palmer, Lanquette, & Jeste, 
2012; Synnot, Ryan, Prictor, Featherstonhaugh, & Parker, 2014; Tamariz, Palacio, Robert, & 
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Marcus, 2012). All of these reviews were restricted to selected publication years, research 
designs, intervention type or a specific cohort. Therefore, the purpose of this review is to 
systematically evaluate single, empirically tested interventions designed at improving research 
participants’ understanding of informed consent for research and report on studies that may have 
been previously excluded. 
Methods 
This review followed the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) method (Moher, Liberati, Tetzlaff, & Altman, 2009). An extensive 
literature search was conducted using Medline, Ovid, PsycINFO, and Cumulative 
Index to Nursing and Allied Heath Literature (CINAHL) databases. The following key words 
were used in various combinations as Medical Subject Headings (MeSH) terms: consent, 
informed consent, research, clinical trials, research participation, research subjects, research 
understanding, research comprehension and interventions. Articles were retrieved if they 
contained any of the key words as a main subject heading. Inclusion criteria were English 
language, reports on empirical studies and publication in a peer-reviewed journal. Exclusion 
criteria were informed consent for surgery or other procedures not specific to research 
participation as this is not the aim of this review, research involving participants with a 
psychiatric disorder or cognitively impaired as this aggregate do not represent the general 
population, research conducted in emergent situations (such as the emergency room or during 
labor), studies examining consent from legal guardians not directly participating in the research 
as this is not the primary aim of this review and research involving children. 
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After conducting an extensive review, 45 articles were abstracted. When reviewing the 
references from all the articles, an additional 15 research studies were retrieved for a total of 60 
articles. 
Results 
From the 60 articles retrieved, 27 were descriptive studies and 8 were systematic reviews 
and therefore did not meet the inclusion criteria. The systematic reviews were not included as the 
intent was to review single interventional studies described in more detail than traditionally 
presented in a review. Twenty five studies met the inclusion criteria (see Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. PRISMA Literature Search Process 
45 records identified through 
database searching 
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Interventions 
Articles describing interventions designed to improve participants’ understanding are 
categorized as follows: 1. modifications to the informed consent form by simplifying the 
language and/or the use of informed consent supplements (n = 12), 2. educational offerings for 
research participants or investigators, (n = 2), 3. monetary rewards to participants as incentives 
(n = 1), 4. communication techniques, (n = 4), and 5. the use of multimedia tools for consenting 
(n = 6). The following is a report of these interventions in chronological order according to 
publication date, within category. Each study was also evaluated for its strength and hierarchy of 
evidence rating where levels range from I, Meta-analysis as the highest level to level VII, expert 
opinion as the lowest, as described by Melnyk and Fineout-Overholt (2011). 
Studies were conducted in several countries including Australia (n = 2), Canada (n = 1), 
Denmark (n = 1), Finland (n = 1), France (n = 1), Malawi (n = 1), Netherlands (n = 1) and the 
United States (n = 17). See Table 1 for all studies’ citations, intervention type and evidence 
rating included in the review listed in alphabetical order by first author’s last name. 
Modifications and/or Supplements to Standard Informed Consent Documents 
 Twelve studies focused on simplifying the language and other modifications to the 
informed consent document or provided supplemental material to improve participants’ 
understanding (Bjorn, Rossel, & Holm, 1999; Campbell, Raisch, Sather, Segal, Warren, & Naik, 
2008; Coletti, Heagerty, Sheon, Gross, Koblin, Metzger, & Seage, 2003; Coyne et al., 2003; 
Davis, Holcombe, Berkel, Pramanik, & Divers, 1998; Dresden & Levitt, 2001; Juraskova et al., 
2008; Paris et al., 2007; Raich, Kennedy, Vanoni, Thorland, Owens, & Bennett, 2012; Stunkel, 
Benson, McClellan, Sinaii, Bedarida, Emanual, & Grady, 2010; Sudore, Landefeld, Williams, 
Barnes, Lindquist, & Schillinger, 2006 & Young, Hooker, & Freeberg, 1990).  
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 Young et al., (1990) studied a sample of 666 consumers who had used a mouthwash 
product within the previous 3 months of enrollment into a hypothetical study. Part of the sample 
read an informed consent document written at the 6th grade reading level and the other part of 
the sample read a document written at the 10th grade reading level (as determined by the Flesch-
Kincaid readability formula). All participants were then given a 21-item investigator developed 
questionnaire to ascertain their comprehension of the research study. Participants were told they 
could take as much as 15 minutes to decide whether or not to participate in the study. There were 
statistically significant higher comprehension scores between those participants who completed 
the survey immediately after reading the consent and those participants who choose to think 
about agreeing to participate or not for fifteen minutes. The participants were then divided into 
educational levels as higher school or less, college, or graduate college level or more. There were 
statistically significant improvements in comprehension the higher the educational level. The 
authors do not state how subjects were assigned to receive either document, nor do they describe 
the 21-item questionnaire used. This study used a quasi-experimental design and is an evidence 
rating of Level III. 
Other investigators modified study leaflets distributed by a major pharmaceutical 
company, by reviewing the layout, style and language in order to improve participants’ 
understanding of the graphics, symbols, and content (Bjorn et al., 1999). Medical language was 
replaced with lay language, long sentences were divided into additional, but shorter sentences 
and long text was broken into smaller sections with headings and subheadings. The revised 
leaflets, one describing a randomized clinical trial (RCT) for a hypertension study, and one 
describing a complex RCT for a new anesthetic used during sterilization, were piloted to 
ascertain participants’ understanding of the  language, the symbols, and the message itself. One 
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hundred thirty-five participants received the hypertension study leaflet and 100 received the 
sterilization leaflet. The authors had participants complete the Summative Cognitive 
Understanding Scale (developed by the authors) where there was a statistically significant 
improvement in understanding with both revised leaflets compared to the original leaflets (Bjorn, 
et al., 1999). This study used a randomized sampling technique which makes this level of 
evidence II.  
Coletti et al. (2003) enrolled and randomized Human Immunodeficiency Virus (HIV) 
research participants into a hypothetical HIV study to evaluate the use of a prototype informed 
consent process. Randomization of sampling makes this study a Level II. Those in the 
intervention group received full disclosure of study information, an informed consent document 
written at 8th grade reading level with enhanced visual displays, intense educational session at 
the time of consenting and a booster educational session 6 months later, with a non-
physician/non-investigator obtaining consent. This intervention had a statistically significant 
higher level of comprehension of key concepts in the informed consent document. Participants’ 
understanding was evaluated using the knowledge questionnaire, developed by the investigators, 
where statements are written as true/false causing even those patients who do not know the 
correct response, a 50% chance of getting the correct answer. The authors do not report any 
psychometric properties of the instrument. 
Sudore et al. (2006) conducted a study to assess research participants’ understanding of a 
short, comprehensive written informed consent document by administering a simple 7-item 
true/false question after participants had the document read to them and had read it for 
themselves with all of their questions answered. Participants were recruited from a general 
medical clinic and were given 3 attempts at providing all correct answers on the test. In addition, 
   
 
49 
 
the authors administered the Short Form Test of Functional Health Literacy in Adults (S-
TOFHLA) measurement of literacy. Sociodemographic variables including age, gender, 
ethnicity, income and educational attainment were also collected. Only 28% of the participants 
answered all 7 questions correctly at the first pass. The authors concluded that low literacy and 
being black were statistically significant indicators for requiring more attempts at passing the test 
(Sudore et al., 2006). This study used a descriptive design with no random sampling and is a 
Level IV.  
Campell et al. (2008) (Level II study) studied the use of a clinical trial handbook as a 
supplement to the standard informed consent document in 146 patients recruited from an 
outpatient clinic in the Veterans’ Affairs Health Care System. Participants were randomized to 
receive the standard informed consent document (n = 62) or the clinical trials handbook (n=84). 
The handbook, developed by experts in research conduct was a full color book explaining the 
basic elements of informed consent for research and was edited until a seventh grade reading 
level was achieved. Participants were asked to rate their understanding of their clinical trial on a 
Likert scale where very clear = +2, to very confused = -2. There was a statistically significant 
improvement in the intervention group including improved understanding of the option to stop at 
any time, side-effects of the experimental treatment, randomization and voluntariness. The use of 
a handbook as a supplement to informed consent seems promising, but these authors do not  
describe the data collection instrument used, but rather, state they modified an existing 
instrument. 
Juraskova et al. (2008) supplemented the standard informed consent document with a 
decision aid (DA) and received feedback on the DA by conducting semi-structure telephone 
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interviews from thirty-one Australian women participating in a breast cancer clinical trial. The 
survey given to participants had been developed by the investigators following an extensive 
literature review, drafts, and editorial revisions, review by a team of investigators and pilot tested 
with healthy volunteers. The authors do not report the survey’s psychometric properties. 
Participants reported the DA assisted them in understanding their research study, with 80% of 
the women answering the purpose and methods of the study correctly. The concepts of 
randomization and blinding were still poorly understood despite the use of the DA. This was a 
descriptive, Level IV study. 
Other investigators have also simplified the informed consent document comparing them 
to standard consent forms. Coyne et al., (2003) compared standard consent forms to a revised 
consent form. Revisions included changes made to the text style, page layout, font size, and 
vocabulary. Readability was reduced to the seventh to eighth-grade level. Assessment of 
understanding was obtained by telephone interviews from trained interviewers to participants. 
Twenty-three true/false and multiple choice questions were asked of participants, but the authors 
do not describe the instrument. There was no significant improvement in understanding between 
either the standard or revised informed consent form. The participants in this study were 
randomized to the standard or simplified consent form making this study a Level II. 
A similar study was conducted by Davis et al., (1998). The investigators compared a 
standard consent form with a 16
th
 grade level to a revised form with a 7
th
 grade reading level. 
Participants were then interviewed to complete a structured, oral 22-question survey  to assess 
for comprehension. Although participants preferred the revised form, there was no significant 
improvement of understanding between the two groups. The authors do not describe 
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randomization of subjects for this study  but did test an intervention giving this study a quasi-
experimental, Level III rating.   
Dresden & Levitt (2001) randomized participants to receive either a standard or a 
shortened informed consent form. Participants read the consent forms and then answered a 13-
question multiple choice test. Reliability and validity of the test is not stated by the authors. The 
group with the shortened consent form had significant improvements in understanding of such 
concepts of purpose of the study, study duration, randomization, risks, benefits, alternative 
treatments and voluntary participation. Again, with randomization this is a Level II study.  
 Paris et al. (2007) randomized (Level II study) 200 healthy volunteers to one of 4 
different versions of the informed consent form: a standard form, a consent form with systematic 
lexico-syntactic readability improvement, a consent form modiﬁed by a working group, and a 
consent form modiﬁed by the working group followed by systematic lexico-syntactic 
improvement. Participants were then asked to discuss what they had read as if they were 
explaining the study to a family member. No questions were asked by the investigator. 
Participants’ responses were tape-recorded. Additionally, participants then completed the QCFic, 
the French adaptation of the Quality of Informed Consent survey. Significant improvements 
were evident in the group which read the consent form modified by working group compared to 
the other three. Exact details of the four consent forms were not described. 
Another study compared standard consent forms to a modified consent forms (Raich et 
al., 2012).  One hundred sixty-two male veterans were randomized to receive either the standard 
or the modified consent form. Telephone interviews were conducted 2 weeks later to assess 
participants’ understanding using 22-item true/false and multiple choice questions. The standard 
consent form had a Flesch-Kincaid reading grade level of 7.9 where the modified consent form 
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had a Flesch-Kincaid reading grade level of 5.6. The group with the modified consent form 
demonstrated significant improvement in understanding. The authors conclude that modifications 
including reading level format and appearance improve understanding of key elements of 
consent. This study was a randomized controlled trial giving it a Level II rating.  
Stunkel et al. (2010) randomized healthy volunteers to read either a standard or a concise 
modified consent form. Comprehension was assessed by a quantitative instrument developed by 
the authors. There was no difference in comprehension between the 14 page consent form or the 
4 page consent form. The authors conclude that too much emphasis is spent on the details in the 
consent forms, possibly due to a fear of legal liability issues. The strength of evidence for this 
study is high due to the randomization of the sample. This is a Level II study. 
Education 
Two studies were found that used education as the intervention. Sengupta, Lo, Strauss, 
Eron, & Gifford (2011) evaluated informed consent understanding among 24 recently enrolled 
(within 1 month) HIV research participants. Participants who scored 85% or lower on the 
Quality of Informed Consent instrument (n = 21) were randomly assigned to receive either a 
targeted educational intervention or a delayed educational intervention in the Level II study. The 
intervention included providing participants with the consent form and a question and answer 
period lasting 20 minutes. Participants’ understanding improved with the targeted intervention as 
compared to the delayed intervention. Understanding was assessed using the Quality of Informed 
Consent (QuIC) instrument, a valid and reliable tool. The authors, however, edited the tool, 
making many modifications to the instrument and deleting some questions.  
Ndebele, Wassenaar, Munalulu, and Maslye (2012) conducted a Level II study to 
evaluate an educational offering among research participants’ who had low scores in a previous 
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study that assessed their understanding of informed consent. For participants who scored less 
than 70% on the 3 concepts of randomization, double-blinding and placebo use, 18 were 
randomized to standard informed consent process and 18 were randomized to receive additional 
education. The educational intervention included a narrative on the study, translated into 
participants’ Native language, ChiChewa, as well as a power point presentation with pictures 
explaining personal implications to the study. Thirteen of the 18 women scored greater than 75% 
on the post evaluation. There was a statistically significant increase in understanding of the 3 
concepts within the intervention group when compared to the standard group. However, the 
authors neither describe the validity of the translated language nor the data collection instrument. 
Results should be replicated with these limitations addressed. 
Monetary rewards 
 One study offered participants a monetary reward as an incentive to comprehension of 
the informed consent material. Apseloff, Kitzmiller, & Tishler (2013) conducted a study to 
determine if receiving a stipend as a reward would increase research participants’ understanding 
of informed consent. Thirty healthy volunteers participating in a clinical trial were administered 
a questionnaire to evaluate their understanding of the informed consent form. Many subjects 
failed to comprehend a variety of basic concepts in the consent form directly impacting their 
clinical trial participation. The specific questions asked were related to the number of blood 
draws, whether the drugs in the study were experimental or not, the number of overnight hospital 
stays required by the study, the likelihood of them receiving a placebo, their right to withdraw 
from the study and other elements including if they felt the informed consent document difficult 
to understand. Demographic information including education, annual income, and employment 
status was also collected. Although only 13% felt the informed consent form difficult to 
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understand, a large percentage failed to comprehend many of the basic concepts of their clinical 
trial, including 33% not knowing if the study drug was experimental or not. However, 97% did 
know their chances of receiving a placebo. The sample size was small, however, and selected 
from a pool of healthy trial participants. In addition, the authors do not disclose the reading level 
of the informed consent document, therefore, we do not know the readability of the document. 
This was a descriptive, Level IV study.  
Communication 
 Four studies empirically tested altered methods of communication that focused on either 
the investigator or the participants. Simes, Tattersall, Coates, Raghavan, Solomon, & Smartt 
(1986) randomized participants to either receive an individual discussion with the 
physician/investigator or the standard policy of total disclosure of all information in a Level II 
study. The participants in the individual approach group received information on the study’s 
aims, expected results and potential risks to treatment. The total disclosure group was told the 
aim of the study, the chance of success, the experimental nature of the study, randomization, 
alternate treatments, possible side-effects, and the ability to withdraw without penalty. Both 
groups were given the opportunity to ask questions. Following this, each participant completed a 
questionnaire specifically designed for this study. Analysis was performed on 55 participants. 
Participants in the total disclosure group were much more knowledgeable about their illness and 
treatment as well as side effects of treatment, the research nature of the study, and 
randomization. This study would suggest that more information leads to better understanding. 
However, the illness severity of the participants as well as how new they may have received a 
devastating cancer diagnosis may play a factor in their abilities to comprehend new information.  
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In a study by Aaronson et al. (1996), 180 cancer patients were approached to participate 
in an oncology research study and randomized to receive either standardized informed consent 
procedure which included a discussion with the physician and a standard informed consent 
document (control group), or standard informed consent procedure plus a telephone conversation 
as a supplement from an oncology nurse (intervention group). The nurses making the telephone 
interviews were trained in telephone interviewing techniques, although this training is not 
described in detail and inter-rater reliability for this intervention was not measured. The 
intervention group had a statistically significant better understanding of risks and side-effects of 
the treatments, the context of the treatments, the purpose of the research study, the concept of 
randomization, the availability of alternative treatments, the voluntary nature of the study, and 
the right to withdraw from the study at any time (Aaronson et al., 1996). The authors conclude 
that this is a rather simple intervention to improve research study participants’ understanding of 
key elements of their research study in this Level II, randomized study.  
Hietanen, Aro, Holli, Schreck, Peura, & Joansuu, (2000) provided a short communication 
course to physicians and nurses enrolling participants into a breast cancer research study. 
Hospitals that were currently conducting a breast cancer study were randomized to be either the 
control group which did not receive the communication course, or the experimental group which 
received the short, one day communication course. The experimental group received training 
from a facilitator experienced in training physicians in communication and included 
psychological reactions to disease, interviewing techniques and the current research 
demonstrating research participants’ lack of understanding. The lecture was followed by role-
playing as both the healthcare provider and the potential research participant. Demographic data 
were collected from both groups. Three and half months after the communication course, 
   
 
56 
 
research participants were surveyed with the Quality of Informed Consent (QuIC) instrument to 
assess their understanding. Three hundred twenty surveys were mailed, with 288 (90%) 
responding. Participants in the intervention group were statistically more satisfied with the 
communication they received when enrolling into their study. Both groups felt they received 
enough information to make an informed decision. Participants in the intervention group felt they 
had been given sufficient time to make a decision, and had a statistically significant increase in 
the understanding of the purpose of the study and the comparison of two study arms. The authors 
also sought feedback from the staff who took the communication course. The physicians and 
nurses all felt the training was very valuable and 80% wished the training had been longer. The 
investigators concluded that the short communication course could be improved upon and be 
valuable for those obtaining informed consent for research. Randomization makes this study a 
Level II.  
Kripalani, Bengtzen, Henderson, & Jacobson (2008) conducted a study of low income, 
inner city African Americans participants recruited from a Primary Care Clinic. The participants 
had previously consented to participate in a research study on medication adherence with 
Coronary Artery Disease and had been randomized to receive or not receive teach back methods 
when explaining their study to them making this a Level II study. Those participants in the teach 
back experimental group were asked to explain back to the investigator key elements of their 
research study. The ability for patients to teach back information ranged from 57.1% to 92.5% 
with lower rates among the elderly and those will lower literacy. The authors concluded that 
teach back allowed investigators to assess participants’ understanding in real time. The author 
suggests that participants with low literacy should be considered a vulnerable population.  
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Multi-media 
 Six studies empirically tested the use of multi-media aids. The term multimedia is used 
when two or more forms or channels of communication are used conjointly such as the use of 
voice and other sound, visual still pictures with motion pictures or computer based 
communication (Palmer et al., 2012). Agre and Rapkin (2003) did not find an improvement in 
research understanding when comparing informed consent delivered by booklet, videotape or 
computer. The authors hypothesized that media tools would lead to better understanding of 
informed consent for  participants in high risk research studies; however, this was not supported 
statistically. This study chose an interesting population from which to draw its sample. The 
sample included a total of 441 individuals, 204 whom were patients at a Day Surgery Center, 109 
were family members and 128 participants, the authors called “surrogate subjects” who were 
individuals waiting for patients in the hospital’s waiting room. Randomized participants’ 
understanding was evaluated on a 12-15 multiple choice knowledge questionnaire developed by 
the authors for this Level II study. The authors concluded that no one in any of the three groups 
were able to correctly answer more than two thirds of the knowledge questions on the 
investigator’s developed survey. As one third of the population was individuals in the waiting 
room, these results may refute the belief that a devastating cancer diagnosis or other health issues 
potential impact on the ability to comprehend the information in the informed consent document. 
Reliability and validity of the survey tool used for this study is unknown.  
Informed consent consultation audiotapes were compared with standard informed consent 
audiotapes in a group of 69 women newly diagnoses with breast cancer in a study by Hack et al., 
(2007). All participants received standard research consent consultations and then randomized to 
receive one of the types of audiotapes, or both. Outcomes were assessed using the Informed 
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Consent Questionnaire adapted by the authors for this study which includes two subscales: The 
Patient Perception of Being Informed (PPBI) subscale and the Patient Knowledge of Information 
Relevant to Informed Consent to Clinical Trials (PKI). There were no statistically significant 
differences in participant knowledge of or perceptions of being informed with the consultation 
audiotape. The authors admit their study is limited by its small sample size and lack of a control 
group. This study was a Level II a Randomized Controlled Trial.  
Bickmore, Pfeifer, and Paasche-Orlow (2009) randomized (Level II) the use of a 
computer agent, versus human communication, versus self-study information on potential 
research participants understanding of informed consent for a hypothetical study. Twenty-nine 
subjects were recruited from a university neighborhood mostly occupied by elder, minority 
adults. Participants’ understanding was assessed using the Brief Informed Consent Evaluation 
Protocol (BICEP). While completing the BICEP, participants were allowed to refer to the paper 
copy of the informed consent document. The investigators also measured participants’ health 
literacy using the Rapid Estimate of Adult Literacy in Medicine (REALM) which has previously 
demonstrated reliability and validity. Participants were then given either the computerized agent 
after a brief session on how to use the computer, human communication about informed consent 
for research or a written informed consent for them to read (with as much time as they needed to 
read it). The human conversation for informed consent was completed by a research assistant 
with experience in this area. Thirteen of the 29 participants (45%) had poor health literacy 
(defined as reading at 8th grade level or below). Analysis revealed that for those participants who 
had adequate health literacy, there was a statistically significant improvement in comprehension 
with both the computer agent and human conversation. For those participants with inadequate 
health literacy, there was no statistically significant difference with comprehension among the 
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three interventions. The authors recognize this study’s generalizability is limited due to the small 
convenience sample used. These authors do not describe if participants were randomized into 
either intervention groups or the control group, we therefore do not know the sampling strategy. 
Kass et al., (2009) also tested the use of a video for improving research participants’ 
comprehension of informed consent. The investigators drew their sample from Oncology patients 
in a large metropolitan area, where participants were randomly assigned to either the intervention 
group where they watched a 20 minute video on clinical trials or the control group which 
received an information pamphlet developed by the National Cancer Institute. The video 
included 5 actors playing the role of patients deciding whether or not to enroll in a research 
study. Two hundred eighty-eight were randomized to receive the video with 130 completing the 
survey questionnaire. Of the 130 who completed the survey, 70 received the computer based 
video and 60 received the pamphlet. A trained investigator interviewed each of the participants 
to garner their knowledge about the purpose, risks and benefits of their study using a structured 
questionnaire developed by the investigators. Participants in the intervention group were 
significantly more likely to understand the purpose of the research study. Interestingly, there was 
no statistically significant difference between the two groups for participants’ beliefs about how 
enrolling in the trial would impact their cancer. 
In a study by Hoffner, Bauer-Wu, Hitchcock-Bryan, Powell, Wolanski, & Joffe, (2012) 
the authors tested the intervention of a video designed to prepare cancer patients with their 
decisions about potential research enrollment. Ninety cancer patients were randomly assigned to 
receive the video (intervention group) or the standard informed consent process (control group). 
The participants completed the Quality of informed Consent (QuIC) instrument, a valid and 
reliable tool, to assess their understanding of the key elements of their research study. All 
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participants also completed additional questions on their satisfaction with the video and 
patient/provider communication. There was no statistically significant difference between the 
groups with objective understanding of informed consent for research. The majority (85%) 
however, felt the video was an important source of information, and 81% felt they were better 
prepared to discuss the research study with their physician (Hoffner et al., 2012). 
McGraw, Wood-Nutter, Solomon, Maschke, Benson, & Irwin (2012) pilot tested video 
vignettes 20 minutes in length with captions and narration after receiving input into its 
development by six African Americans and six non- Hispanic white individuals for clarity and 
content. Patients visiting several local Oncology clinics were recruited to participate. 
Recruitment was specifically designed to capture a widely diverse group of racial and ethnic 
backgrounds and educational levels. Forty-three participants were randomized to read an 
informed consent document or view the multi-media video with vignettes, then participate in a 
semi-structure interview. Twenty-two of the 32 participants (68%) who viewed the video felt it 
to be very useful and provided them with enough information to make an informed decision. Ten 
participants, however, felt the video alone was not enough and asked for additional resources. 
The most common complaint about the video was the length. Participants felt it too lengthy and 
tedious, especially the parts of the video that spoke about the role of the Institutional Review 
Board (IRB). Both groups had a good understanding that the benefits of research was primarily 
for future patients. Although more than half of the participants knew they might be contacted for 
future research, less than one fifth said they would refuse to participate, leaving the investigators 
to wonder if they did not fully appreciate the voluntary nature of research participation. This 
study’s design and sampling make is a Level II.  
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Discussion 
Studies assessing research participants’ understanding of their specific study, have 
identified issues with lack of comprehension. This problem has been researched and described 
for more than twenty-five years. Several approaches have been taken to improve research 
participants’ understanding, which included altering the language in the informed consent 
document, providing supplemental information or additional education, or the use of multi-media 
tools or altered communication techniques.  
Several systematic reviews on interventions to improve research participants’ 
understanding of informed consent have previously been published but were limited to 
publication years (Dunn & Jeste, 2001; Cohn & Larson, 2007; Montalvo & Larson, 2014),  
research design (Nishimura et al. (2013), intervention type (Palmer et al., 2012; Synnot et al., 
2012), or specific cohort (Tamariz et al., 2012). This systematic review addressed these gaps but 
not applying those exclusionary criteria, but rather taking a more inclusive review of current 
research.  
Each of the 25 studies reviewed were rated according to the hierarchy of evidence 
described by Melnyk and Fineout-Overholt (2011). The majority of the studies (n = 20) were 
Level II, a single randomized study. Two studies were Level III, due to non-randomization of the 
sample and 3 studies were Level IV, descriptive. Although all of the studies described research 
design and sample selection, none of the studies explained how the investigators arrived at their 
sample size. The authors acknowledged when they had a small sample which begs one to wonder 
why an a priori power analysis was not done. Therefore, it would appear as though many of 
these studies, though well designed might be underpowered. If this is the case, the results must 
be viewed with caution. Additionally, none of the communication studies was longitudinal and 
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therefore it is unknown whether a change in communication patterns and methods can be 
sustainable over time.  
There are instruments currently available to measure research participants’ understanding 
that have demonstrated reliable psychometric properties (Joffe et al., 2001; Sugarman, McCrory, 
Powell, Krasny, Adams, Ball, & Cassell, 2005). Despite this, only 6 studies used a valid and 
reliable instrument to gather quantitative comprehension scores. The majority of studies were 
conducted with instruments developed by the authors. A major limitation of these studies 
therefore, is the unknown reliability and validity of the instruments. This jeopardizes the internal 
consistency of the study and limits the generalizability of the results. Other research used 
hypothetical studies which begs one to wonder if participants would be less concerned with risks 
involved in enrollment, knowing the study is not actually occurring. The majority of the studies 
examining participants’ understanding did so several weeks to months after the informed consent 
discussion which may introduce recall bias. Some studies have admittedly recruited a small 
sample size, and therefore may be underpowered. Results should be interpreted with caution 
Lastly, the use of a theoretical framework supporting empirical research on informed 
consent has been absent from the literature. Meade (1999) suggests researchers look towards 
communication or adult education for theoretical frameworks to support future studies. Although 
none of the studies described in this review reported on the use of a theoretical framework it is 
believed that an intervention is more likely to be effective if based on a model or theory (Conn, 
Rantz, Wipke-Tevis, & Maas, 2001).  
Limitations 
This review set out to be more inclusive of the literature than previously published 
reviews; however it does have some limitations. First, it only included articles which have been 
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published in English. Although a comprehensive literature search was conducted, it is possible 
that some relevant articles may have been missed. Abstract presentations, dissertations and 
unpublished work are not reported here which may result in reporting bias. 
  Conclusions 
More research is needed that addresses the limitations of the studies described in this 
review. Well-designed research studies with support of a theoretical framework, use of valid and 
reliable instruments, a randomized sampling strategy and enrollment of a large enough sample to 
have adequate power to determine statistical significance may yield interesting results and allow 
for strategies to improve participants’ understanding to be implemented into practice. Without 
well-designed studies demonstrating reliable interventions for improving research participants’ 
understanding this 25 year old problem will persist.  
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Table 1. Citations in Systematic Review  
Citation Purpose Intervention  Evidence 
Hierarchy 
Aaronson et al. (1996). Telephone-based nursing interventions 
improves the effectiveness of the informed consent process in cancer 
clinical trials. Journal of Clinical Oncology, 14, 984-996. 
To test a telephone intervention 
to increase participants’ 
understanding of their clinical 
trial. 
Communication RCT 
Level II 
Agre, P., & Rapkin B. (2003). Improving informed consent: A 
comparison of four consent tools. IRB: Ethics & Human Research, 
25(6), 1-7. 
To measure the effectiveness of  
videotape, computer, and booklet 
format-against the standard 
written consent form. 
Multi-media RCT 
Level II 
Apeseloff, G., Kitzmiller, J.P., & Tischler, C. L. (2013). Credibility 
and comprehension of healthy volunteers in lengthy inpatient drug 
studies.  
To assess motivation, 
comprehension and the effects of 
offering a stipend on knowledge 
of clinical trial.  
Monetary Reward Descriptive 
Level IV 
Bickmore, T.W., Pfeifer, L.M., & Paasche-Orlow, M.K. (2009). 
Using computer agents to explain medical documents to patients 
with low health literacy. Patient Education Counseling, 75(3): 315-
320. 
To evaluate an animated 
computerized agent to explain 
research consent forms to 
potential research participants 
Multi-media RCT 
Level II 
Bjorn et al. (1999). Can the written information to research subjects 
be improved? An empirical study. Journal of Medical Ethics, 25, 
263-267. 
To determine if changes made to 
information leaflets from clinical 
trials improved perceived 
difficulty and understanding of 
the content. 
Modifications to the 
Informed Consent 
Document 
RCT 
Level II 
Campbell et al.  (2008). Impact of a clinical trials information 
handbook on patient knowledge, perceptions, and likelihood of 
participation. IRB: Ethics & Human Research, 30(1), 6-14. 
To assess an Informed Consent 
Handbook on participants’ 
understanding of informed 
consent. 
Modifications to the 
Informed Consent 
Document 
RCT 
Level II 
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Coletti  et al. (2003). Randomized, controlled evaluation of a 
prototype informed consent process for HIV vaccine efficacy trials. 
Journal of Acquired Immune Deficiency Syndrome, 32, 161-169. 
 
To test a prototype informed 
consent process to improve 
participant understanding 
 
Modifications to the 
Informed Consent 
Document 
 
RCT 
Level II 
Coyne et al. (2003). Randomized, controlled trial of an easy to read 
informed consent statement for clinical trial participation: A study of 
the Eastern Co-operative Oncology Group. Journal of Clinical 
Oncology, 21(5), 836-842. 
To evaluate a modified easy to 
read informed consent document 
on patient anxiety, satisfaction 
and understanding of their 
clinical trial.  
Modifications to the 
Informed Consent 
Document 
RCT 
Level II 
Davis et al. (1998). Informed consent for clinical trials: A 
comparative study of standard versus simplified forms. Journal of 
the National Cancer Institute, 90(9), 668-674. 
To compare a standard consent 
written at 16
th 
grade reading level 
to a simplified form written at 7
th
 
grade reading level. 
Modifications to the 
Informed Consent 
Document 
Quasi-
experimental 
Level III 
Dresden, G. M. & Levitt, A. (2001). Modifying a standard industry 
clinical trial consent form improves patient information retention as 
part of the informed consent process. Academic Emergency 
Medicine, 8(3), 246-252. 
To ascertain patient retention of 
information from an industry 
sponsored consent form 
compared to a condensed, 
simplified form 
Modifications to the 
Informed Consent 
Document 
RCT 
Level II 
 
Hack et al. (2007). Standardized audiotape versus recorded 
consultation to enhance informed consent to a clinical trial in breast 
oncology. Psycho-Oncology, 16, 371-376. 
 
To compare two audiotape 
formats for the delivery of 
informed consent to  
 
Multi-media 
 
RCT 
Level II 
 
Hietanen, et al. (2007). A short communication course for physicians 
improves the quality of patient information in a clinical trial. Acta 
Oncologica, 46, 42-48.  
 
 
 
To determine if a communication 
course would improve 
participants’ understanding of 
their clinical trial. 
 
Communication 
 
RCT 
Level II 
Hoffner et al. (2012). Entering a clinical trial: Is it right for you? A 
randomized study of the clinical trials video and its impact on the 
informed consent process. Cancer, 118(7), 1877-1883. 
To assess an educational video in 
preparing cancer patients for 
enrollment into a clinical trial 
Multi-media RCT 
Level II 
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Juraskova  et al. (2008).  Improving informed consent: Pilot of a 
decision aid for women invited to participate in a  breast cancer 
prevention trial (IBIS-II DCIS). Health Expectations, 11, 252–262. 
 
To pilot test a decision aid 
booklet to improve participant 
understanding of informed 
consent 
 
Modifications to the 
Informed Consent 
Document 
 
Descriptive 
Level IV 
 
Kass et al. (2009). An intervention to improve cancer patients’ 
understanding of early phase clinical trials. IRB: Ethics & Human 
Research, 31 (3), 1-10. 
 
To test a computer-based tool and 
pamphlet with cancer patients 
who were considering enrolling 
in an early-phase clinical trial. 
 
Multi-media 
 
RCT 
Level II 
Kripalani S, Bengtzen R, Henderson L, & Jacobson T. (2008). 
Clinical research in low-literacy populations: Using teach back to 
assess comprehension of informed consent and privacy information. 
IRB: Ethics & Human Research, 30 (2), 13-19. 
To examine the  association of 
patients’ age, cognition, years of 
education, and literacy level with 
comprehension of informed 
consent 
Communication RCT 
Level II 
 
McGraw et al. (2012). Clarity and appeal of a multi-media informed 
consent tool for biobanking. IRB: Ethics & Human Research, 34(1), 
9-19. 
 
What information regarding 
domains of informed consent  in 
the multimedia tool and written 
consent document was salient to 
the participants 
 
Multi-media 
 
RCT 
Level II 
 
Ndebele, P.M., Wassenaar, D., Munalula, E., & Masiye, F. (2012). 
Improving understanding of clinical trial procedures among low 
literacy populations: An intervention within a microbicide trial in 
Malawi. BMC Medical Ethics, 13, 29 
 
To assess participants’ 
understanding of randomization, 
double-blinding and placebo use. 
 
Education 
 
RCT 
Level II 
 
Paris et al. (2007). Improvement of the comprehension of written 
information given to healthy volunteers in biomedical research: A 
single-blind randomized controlled study. Fundamental & Clinical 
Pharmacology,21, 207–214. 
 
To identify if improvement in 
lexico-syntactic readability could 
increase comprehension of  
information given to volunteers 
enrolled in biomedical research 
 
Modifications to the 
Informed Consent 
Document 
 
RCT 
Level II 
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Raich, et al. (2012). Improved understanding and satisfaction with a 
modified informed consent document: A randomized study. Patient 
Intelligence, 4, 23-39. 
 
To assessed the impact of an 
informed consent process 
 
Modifications to the 
Informed Consent 
Document 
 
RCT 
Level II 
 
Sengupta, S., Lo, B., Strauss, R.P., Eron, J., & Gifford, A.L. (2011). 
Pilot study demonstrating effectiveness of targeted education to 
improve informed consent understanding in AIDS clinical trials. 
AIDS Care, 23(11), 1382-1391. 
 
To pilot test an educational 
intervention to improve actual 
informed consent understanding 
 
Education 
 
RCT 
Level II 
 
Simes, R.J., Tattersall, M.H., Coates, A.S., Raghavan, D., & 
Solomon, H.J. (1986). Randomized comparison of procedures for 
obtaining informed consent in clinical trials of treatment of cancer. 
British Medical Journal, 293, 1065-1068.  
 
To compare 2 methods of consent 
to randomized treatment. 
 
Communication 
 
RCT 
Level II 
 
Stunkel et al. (2010). Comprehension and informed consent: 
Assessing the effect of a short consent form. IRB: Ethics & Human 
Research, 32(4), 1-9. 
 
To evaluate the effect of a shorter 
and simpler consent form on the 
comprehension of research 
participants. 
 
Modifications to the 
Informed Consent 
Document 
 
RCT 
Level II 
 
Sudore et al. (2006). Use of a modified informed consent process 
among vulnerable patients: A descriptive study. Journal of General 
Internal Medicine, 21, 867-873. 
 
To determine whether literacy 
and demographics  are associated 
with understanding consent 
information. 
 
Modifications to the 
Informed Consent 
Document 
 
Descriptive 
Level IV 
 
Young et al. (1990). Informed consent documents: Increasing 
comprehension by reducing reading level. IRB: Ethics & Human 
Research, 12(3): 1-5. 
 
To understand the impact of 
informed consent reading level on 
subjects’ comprehension. 
 
Modifications to the 
Informed Consent 
Document 
 
Quasi-
experimental 
Level III 
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Chapter Summary 
 This chapter included two manuscripts for submission for publication. The first 
manuscript is a critique to the Shannon-Weaver Communication theory. The Shannon-Weaver 
Communication theory may serve as a framework for future nursing studies employing teach 
back, patient hand-offs or other aspects of nursing communication. A thorough critical review of 
the theory is warranted if it is to be applied to nursing and a critique of this theory has not 
previously been published.  
 The second manuscript describes a systematic review of the literature to examine 
interventions tested to improve research participants’ understanding of informed consent. This 
systematic review describes interventions previously tested and allows the reader to understand 
the depth and breadth of the issue and various methods attempted at making improvements in 
research participant understanding. Armed with this information the following chapter describes 
the research design used to test the teach back method of communication for improvements in 
research participants’ understanding of informed consent.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
     
76 
 
CHAPTER 3 METHODS 
 
The research questions, hypotheses, methods, design, sampling strategies, intervention 
and data collection and analytical methods used for this study are presented in this chapter.  Also 
included are limitations and processes for protection of human subjects. The teach back process 
of communication intervention is described.  
Research Questions and Hypotheses 
The research questions driving this study were 1. In research participants, will the use of 
the teach back method of communication compared to standard language, improve objective 
understanding of informed consent? 2. In research participants, is the relationship between 
objective and subjective understanding different in the control group (standard communication) 
compared to the experimental group (teach back communication)?  
The following hypotheses were proposed for testing in this study: participants will have a 
greater understanding of the risks, benefits and other key elements of their research study after 
receiving the teach back process of communication. A secondary hypothesis is that there will be 
less of a difference between objective and subjective understanding within the experimental 
group.  
Methods 
Design 
This study used a quasi-experimental sequential two group design with pre and post 
intervention groups. The pre-intervention group served as the control group and the post 
intervention group, the experimental group. This design was chosen as it was impractical in the 
clinical setting to randomize the participants.  
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Setting 
This study was conducted at a large, tertiary care hospital in New England. The hospital 
serves as a major cardiology referral center for the state. The Cardiology department is actively 
participating in 7 national clinical trials.  
Sample 
This study used a convenience sample of 52 adult Cardiology patients (38 for the pre-
intervention group and 14 for the post intervention group) identified by the Cardiology Research 
Coordinators when accessing their database for potential Cardiology clinical trial participants. 
The sample was drawn from participants in two cardiac clinical trials that were open at the time 
of recruitment. Inclusion criteria were English speaking and writing and enrolled in a cardiac 
clinical trial. Exclusion criteria were: 1) under the age of 18 years, 2) a current diagnosis of 
dementia, Alzheimer’s or who are otherwise cognitively impaired or diagnosed with a mental 
illness, and  3) participation in a research study where assent was given by a legal guardian or 
someone other than the participant themselves.  
A total of 74 participants was targeted as the sample size (A1 Therapy Statistics, 2016). 
To determine sample size, Cohen (1988) states there is a β of .2 or a 20% probability of failing to 
detect an effect when there is one (a Type II error). Therefore there is 1-β or a .8 or 80% 
probability of detecting an effect when there actually is one. The last number needed to 
determine a power analysis is the effect size. According to Cohen (1992), a small effect size is (r 
= .1), a medium effect (r =.3) and a large effect size (r = .5).  
Only one prior research study has tested the use of the teach back process of 
communication as an intervention to improve research participants’ understanding of informed 
consent (Kripalani et al., 2008).  According to Hulley, Cummings, Browner, Grady, & Newman 
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(2007) when there is no a priori data on which to establish the effect size, the investigator may 
conduct a pilot study. Field (2011) suggests in the absence of prior research, the researcher needs 
to estimate the likely effect size based on similar studies.  For this study the effect size was 
estimated to be large. Therefore, with an α of .1, power of .8 and effect size of .5, the estimated 
sample size for this study was 37 participants in each group.  
Measurement 
Participant Demographics. Demographic data were collected to describe the subjects. 
This included age, gender, socio-economic status and educational level.  
Socioeconomic Status. It is believed that participants’ socioeconomic status as measured 
by their educational level and income may impact their ability to read and understand their 
informed consent document. This may or may not have an impact on their ability to understand 
and comprehend the research study in which they are participating and therefore was collected 
and analyzed as a confounding variable. Socioeconomic status was measured by household 
income as defined by the United States Census Bureau. Years of completed education was 
collected as it may have an impact on participants’ ability to read and understand the informed 
consent document. This can be found in Appendix C. 
 Instrument. The Quality of Informed Consent (QuIC) instrument was developed by 
Joffe et al. (2001). The overall purpose of the instrument was to evaluate participants’ 
understanding of their clinical trial. The authors started with the basic elements of informed 
consent outlined in federal regulations (Code of Federal Regulations, 2012). These included 
elements such as the voluntary nature of the research, the risks and benefits, the use of Protected 
Health Information, the cost to the participant as well as other key points that must be in the 
consent form. However, some of these elements (such as “benefits to the subject or to others”) 
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are actually a synthesis of two or more different concepts and therefore, Part A of the QuIC 
contains 20 questions that include 13 distinct domains of informed consent measuring objective 
understanding. Questions are answered on a Likert scale from 1 (disagree), 2 (unsure) and  
3 (agree). Each correct answer in Part A is given a score of 100 points, an “Unsure” response is 
given a score of 50 points and incorrect answers are given 0 points. Unanswered questions are 
not scored.  
Part B of the instrument measures subjective understanding which assesses what 
participants believe they understand (Joffe et al. 2001). Part B of the instrument contains 14 
questions answered on a Likert scale from 1 (I didn’t understand this at all), to 5 (I understood 
this very well). Part B of the QuIC is scored by taking the average responses to each of the 
fourteen questions and scaled from 0-100 (summary score = raw average -1 x 25). This allows 
for equal weighting among the domains in the instrument.  
Part A of the instrument, participants’ objective understanding was the primary outcome 
variable of interest in this intervention study. It was hypothesized that participants believe 
themselves to be informed when in reality are not. This hypothesis is supported by previous 
research where as many as 90% of participants were satisfied with the informed consent process 
and believed themselves to be fully informed, but when questioned in more detail, were unaware 
of the purpose of the study, the unproven nature of the intervention and other aspects of their trial 
(Joffe et al., 2001). Therefore, Part B of the QuIC instrument was used to assess participants’ 
beliefs about being informed about their study. The QuIC is written at an 8th grade reading level. 
The interclass correlation coefficient (ICC) was .66 (Part A). It was noted that subjects with 
lower scores had greater test–retest variability than those with higher scores. Part A of the QuIC 
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instrument had a mean score of 76 and Part B summary scores averaged 87.2 and the interclass 
coefficient was .77 during pilot testing of the instrument (Joffe, et al., 2001). 
 Informed Consent Form. The Flesch-Kincaid readability of the informed consent form 
may impact participants’ ability to read and understand their consent and was collected as a 
potential confounding variable. 
Procedures 
 
Human subjects protection. This research proposal was approved by the Institutional 
Review Board (IRB) at the University of Wisconsin-Milwaukee where the Principal Investigator 
was a student (Appendix A) and the IRB at the participating hospital (Appendix B).  
Teach back intervention. The intervention for this study was the teach back process of 
communication. Teach back has been defined as “asking patients to repeat in their own words 
what they need to know or do, in a non-shaming way” (The Ethics Center, 2006, p. 2). Teach 
back is a communication method used to enhance comprehension and retention of information, 
and assess for understanding (Wilson, Mayeta-Peart, Parada-Webster, & Nordstrom, 2012). 
During teach back, the patient or participant is asked to repeat back to the educator, in their own 
words what they heard. This allows for assessment of understanding and the correction of any 
misinformation.  
 The Cardiology Research Coordinators at the participating hospital are Registered 
Nurses holding certifications from the Society of Clinical Research Association (SOCRA) or 
from the Association of Research Professionals (ACRP). Passing the certification exam from 
either of these national organizations allows the nurse to use the credential, Certified Clinical 
Research Coordinator (CCRC). The certification demonstrates competence and expertise in 
preparing or reviewing documents submitted to the Institutional Review Board (IRB),  protocol 
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review and study procedures, planning, maintaining source documents, preparing for study site 
visits from a monitor, sponsor, or auditor, and obtaining informed consent. The Cardiology 
Research Coordinators are responsible for obtaining informed consent for all clinical trials within 
the department at the study site.  
The curriculum for the teach back education was developed by the Student Principal 
Investigator who has previously been educated in teach back. The Teach Back curriculum 
included the purpose of the presentation, objectives, the Institute of Healthcare Improvement’s 
(IHI) top patient safety measures, background on health literacy, a review of research describing 
communication challenges in healthcare and its impact on patients, a review of research on 
participant miss-understanding of their clinical trial, definition of teach back, examples of plain 
language, goals of teach back, a short teach back video demonstration, examples of questions to 
elicit teach back, and references. 
The teach back education consisted of power point slides (Appendix G) provided to the 
Cardiology Research Coordinators as a live class, including a video of a demonstration of teach 
back. This educational presentation was approved for 1.0 contact hour of continuing nursing 
education by the Northeast Multi-state Division Continuing Nursing Education, an accredited 
approver by the American Nurses Credentialing Center’s Commission on Accreditation.  
Immediately after the educational session, the Cardiology Research Coordinators 
completed a 10-question quiz covering the educational content (Appendix H). The quiz was 
developed by the Student Principal Investigator and reviewed by a nursing faculty colleague for 
content and formatting of questions. The nursing faculty colleague has several years of 
experience as nursing faculty, holds a Master’s Degree in Nursing Education and is certified in 
Nursing Education by the American Nurses Credentialing Center (ANCC). Interrater reliability 
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was achieved by the coordinators attaining a passing score of 90% or better on the quiz therefore 
establishing an inter-rater reliability of .90 or higher. If this score was not achieved, teach back 
content would have been reiterated with more demonstrations, role playing and a question and 
answer session until a minimal interrater reliability score of .90 was achieved. Inter-rater 
reliability values of 75- 90% (.75-.90) are considered acceptable levels of agreement (Barrett, 
2001; Stemler, 2004). 
Data Collection 
Informed Consent Form 
A blank copy of the informed consent form (ICF) that each participant had signed for 
their specific study was evaluated for reading level with the Flesch-Kincaid reading score.  
Pre-intervention (Control Group)  
 Cardiac clinical trial participants, who signed informed consent and were currently 
participating in one of the departments open cardiology clinical trials, were mailed a study 
packet. The study packet contained a cover letter explaining the study (Appendix C), the 
demographic data collection tool (Appendix D), the QuIC instrument (Appendix E) and a 
stamped, addressed return envelope. As a strategy to potentially increase response rate, a 
reminder postcard was mailed 2 weeks after the study packet was mailed (Appendix F) (Dillman, 
1991). All data collected by the Student Principal Investigator (SPI) (a total of 18 surveys) were 
kept in a locked file cabinet drawer in the SPI’s locked office. Participants were assigned a study 
ID number consecutively beginning with 001. No Protected Health Information (PHI) was linked 
to the assigned study ID number.  
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Post Intervention (Experimental Group)  
 Fourteen cardiology clinical trial participants who signed consent after the teach back 
intervention were enrolled into the post-intervention group. Four participants were mailed the 
study packet. The study packet contained a cover letter explaining the study (Appendix C), the 
demographic data collection tool (Appendix D), the QuIC instrument (Appendix E) and a 
stamped, addressed return envelope. A reminder postcard was mailed two weeks later. Ten study 
packets were hand-delivered to potential participants per the research coordinator’s request. A 
total of 5 surveys were returned for a 36% response rate.  
Data Analysis 
Data Management 
Scores on the QuIC were calculated by the SPI, per the authors’ instructions (Joffe et al., 
2001). Data were then entered into the Statistical Package for Social Sciences (SPSS) v. 21. 
Returned surveys were reviewed by the student PI for completeness and missing data. Data were 
periodically checked by the SPI throughout the data collection process to examine for any odd 
findings or outliers.  
Preliminary Analyses 
Descriptive statistics (means and frequency distributions) were used for demographic 
variables to describe the study sample. Descriptive statistics were used to describe the pre and 
post-intervention groups’ responses on the QuIC. The analyses included number and percentage 
of correct answers, and mean scores by domain. 
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Primary Analyses 
To answer the study’s primary research question, In research participants, will the use of 
the teach back method of communication compared to standard language, improve objective 
understanding of informed consent, an independent samples t-test was conducted. To answer the 
study’s secondary research question,  In research participants, is the relationship between 
objective and subjective understanding different in the control group (standard communication) 
compared to the experimental group (teach back communication) an independent samples t-test 
was conducted.  
Additional Analyses 
A Chi square test was used to explore the relationships of the categorical variables of 
education, income and history of research participation to the mean scores on the QuIC for the 
pre and post intervention groups. 
Limitations 
There were a few limitations to this research that merit discussion. First, is the sampling 
method. Ideally, randomization of participants would be preferred. Unfortunately, that is not 
possible within the current infrastructure of the setting for this research study. As Conn et al.,  
(2001) state, research studies conducted in real world settings often 
must compromise one aspect of an experiment in order to gain control over a more important 
source of variations within the study. Another limitation is that participants’ were asked to recall 
the informed consent process. While the literature recognizes that recall, or memory and 
comprehension or understanding are two distinct concepts, (Dunn & Jeste, 2001; Falagas, 
Korbila, Giannopoulou, Kondilis, & Peppas, 2009)  there is the potential for recall bias from the 
participants. The third limitation is the lack of blinding for the research coordinators. The 
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research coordinators were aware of the objectives of the study prior to the intervention and thus 
introduces the potential for bias.  
 Chapter Summary 
This chapter described the methods used to examine research participants’ 
understanding of informed consent. Specifically, to test whether or not using the teach back 
method of communication improved research participants’ understanding of key elements of 
informed consent when agreeing to participate in a cardiology clinical trial. Procedures 
throughout the study have been described including the study’s limitations. The following 
chapter will describe preliminary and primary analyses, and includes the third manuscript of the 
pre-intervention group study results. 
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CHAPTER 4 RESULTS 
 
 This chapter begins with a description of data cleaning procedures and preliminary 
analyses for both the pre and post intervention groups. The primary analyses follows. The third 
manuscript is included and focused on the results of the pre-intervention group only including 
descriptive analyses. Finally a summary concludes the chapter.   
Preliminary Analyses: Pre-intervention Group 
Data Cleaning 
All data were entered into the Statistical Package for Social Sciences (SPSS v. 22). When 
conducting human subject research it is rare to have a complete dataset (Pallant, 2010). This is 
true of this study where two pre-intervention surveys were returned with missing data. Missing 
data were coded 
-
.9, a unique code not corresponding to any numeric data on the survey. Missing 
data were not used in computing summary statistics and the denominators were changed 
appropriately (Smith, Budzeika, Edwards, Johnson, & Bearse, 1986). Two participants in the 
pre-intervention group (11% of the sample) did not answer question A17 on the QuIC, a question 
on the concept of payment for research-related injury. One of these participants (6% of the 
sample) also did not answer question A 18. Question A18 seeks to identify if the participant 
knows who to contact should they have any questions about their clinical trial. These omissions 
of data are considered illegitimate missing data according to Osborne (2013). Illegitimate 
missing data can occur when participants intentionally or unintentionally skip a survey question. 
Given that two participants (11%) did not answer the same question, A17, may infer this data is 
missing not at random (MNAR) and could potentially result in bias (Osborne, 2013). Mean 
scores were calculated from only responses with valid values and denominators were changed 
appropriately to accurately reflect the number of completed responses on the QuIC (Smith et al., 
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1986). When analyzing results for Part A of the QuIC, scores were calculated according to the 
author’s instructions (Joffe et al., 2001).   
Before beginning data analysis it is imperative to check for any inadvertent errors in the 
data. Undetected errors can greatly affect the data analysis (Pallant, 2010). Data cleaning 
procedures were completed in SPSS per recommendations found in Pallant (2010). This included 
running frequencies for each of the answers on the QuIC. Both categorical variables and 
continuous variables were checked for accuracy and no errors were found in the data.  
Descriptive Analyses 
The next step was descriptive analysis to check for assumptions. This was first done by 
looking at sample distributions by running descriptive statistics on the pre-intervention group  
(n = 18). Frequencies were assessed for all questions on the QuIC. For the categorical variables, 
descriptive statistics were run and frequencies were examined. For continuous variables, 
descriptive statistics were run including an examination of skewness and kurtosis. Skewness of a 
sample describes the symmetry of the distribution whereas the kurtosis describes the peak of the 
distribution. If both skewness and kurtosis were normally distributed a value of 0 for each would 
be seen. A negative skewness indicates a clustering of scores at the high end, or right side of a 
graph, with positive skewness indicating a clustering of scores at the left, or low end. 
The general rule to follow is a skew of +2 to 
-
2 range is considered normal distribution 
(Garson, 2012). A positive kurtosis indicates the sample distribution to be peaked (Pallant, 
2010). For this sample a skewness of 
-
1.4 and a kurtosis of 1.25 were noted. A Kurtosis of +2 to 
-
2 is also considered normal distribution (Garson, 2012). These results indicated there was a 
normal distribution to the sample. 
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Assessing normality of the sample was completed by comparing the mean and trimmed 
mean scores. To obtain trimmed mean scores the top and bottom 5% of cases were removed and 
a new mean value was calculated. This allowed for a comparison of the original mean value to 
the new trimmed mean value to determine if there were any extreme scores influencing the 
mean. When comparing scores for both Part A mean and trimmed mean the scores were 75.44 
and 75.38 respectively. Scores this similar indicate there were no extreme scores in the sample 
influencing the means (Pallant, 2010). The mean and trimmed mean scores for Part B were 88.72 
and 89.61 respectively, again, indicating no extreme scores influencing the means. Additionally, 
the Schapiro-Wilk’s W test was conducted to determine distribution. The Shapiro-Wilk’s W test 
is recommended for small samples (Garson, 2012). The results were non-significant for the QuIC 
Part A indicating a normal distribution but were significant for Part B scores indicating an 
uneven distribution. Finally histograms and a Normal Q-Q Plot were evaluated in SPSS where 
no outliers were observed.  
Descriptive analyses including frequencies and percentage distributions were conducted 
on questions on the QuIC instrument and are reported in Manuscript Three. 
Preliminary Analyses: Post-intervention Group 
Data Cleaning 
All data were entered into the Statistical Package for Social Sciences (SPSS v. 22). When 
analyzing results for Part A of the QuIC, scores were calculated according to the author’s 
instructions (Joffe et al., 2001).   
Before beginning data analysis it is imperative to check for any inadvertent errors in the 
data. Undetected errors can greatly affect the data analysis (Pallant, 2010). Data cleaning 
procedures were completed in SPSS per recommendations found in Pallant (2010). This included 
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running frequencies for each of the answers on the QuIC. Both categorical variables and 
continuous variables were checked for accuracy and no errors were found in the data.  
Descriptive Analyses 
The next step was descriptive analysis to check for assumptions. The same procedures for 
preliminary analysis for the post intervention group (n = 5) were conducted as described above 
for the pre-intervention group. For the categorical variables, descriptive statistics were run and 
frequencies were examined. For continuous variables, descriptive statistics were run including an 
examination of skewness and kurtosis. For this sample a skewness of 
-
.901 and a kurtosis of 1.47 
were noted. This sample was found to have a normal distribution.  
To assess normality the mean and trimmed scores were examined. For Part A of the QuIC 
were 68.43 and 68.56 respectively. For Part B of the QuIC the mean and trimmed mean scores 
were 80.28 and 81.58 respectively. The Shapiro-Wilk’s W test indicated a normally distributed 
sample. Finally histograms and a Normal Q-Q Plot were evaluated in SPSS where no outliers 
were seen.  
Pre-intervention Sample Demographics 
The sample included 12 males (67%) and 6 females (33%). Ages ranged from 36-84 
years with a mean age of 66.6 years (SD = 17.35). See Table 4 for other sample demographics. 
The Flesch-Kincaid readability statistics for the cardiac clinical trial consent form signed by this 
cohort included the following: number of pages = 15, number of words = 5115, average number 
of words per sentence 19.1, and grade level 10.5. 
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Results of QuIC Part A 
The total scores on the QuIC Part A (objective understanding) ranged from 55.76 to 
96.15 out of a possible 100 with a mean score of 75.44 (SD = 12.86). See Table 4 for QuIC 
domains, concepts and percentage correct.  
One area of misunderstanding was that of an explanation as to whether any compensation 
and an explanation as to whether any medical treatments are available if injury occurs, and if so, 
what they are and where to access further information. This concept is captured in Domain 11. 
Fifty percent of respondents answered this question correctly while the remaining 50% were 
either unsure or answered incorrectly. Here the mean score was 69.0 (SD = 35.93) with a range 
of scores from 0-100. 
Other difficulties in understanding the concepts within the informed consent were found 
in Domain 4, (see Table 4), a description of the procedures to be followed. This domain includes 
two statements on the QuIC. Here, only 7 out of 18 participants (39%) answered correctly 
(scores ranged from 50-100 with a mean score of 78.0 (SD = 20.8). Further analyses and 
discussion for the pre-intervention group are found within the manuscript later in this chapter.  
Teach Back Intervention 
 Teach back education was presented by the Student Principal Investigator (SPI) to two 
of the three Cardiac Clinical Research Coordinators (Appendix G). The education was held in 
the private office of one of the coordinators. Immediately after the educational session, the 
Cardiology Research Coordinators completed a 10-question quiz covering the educational 
content (Appendix H). Interrater reliability was achieved by the coordinators attaining a passing 
score of 90% or better on the quiz therefore establishing an inter-rater reliability of .90 or higher. 
Inter-rater reliability values of 75- 90% (.75-.90) are considered acceptable levels of agreement 
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(Barrett, 2001; Stemler, 2004). Although the two research coordinators were satisfied with the 
education and felt it would improve participants’ understanding, one limitation was the inability 
to observe whether or not teach back was actually used during the subsequent informed consent 
process.  
Intervention Implementation 
 Following the educational intervention 4 study packets were mailed followed by a 
reminder postcard 2 weeks later. Ten study packets were hand delivered to participants for a total 
of 14 study packets. Five surveys were returned (36% response rate).  
Post Intervention Sample  
The sample was 5 males (100%). Ages ranged from 67-88 years with a mean age of 75.8 
(SD = 8.70) years. See Table 4 for other sample demographics. The informed consent documents 
signed by the post intervention group included the following: pages = 13, words = 4179, average 
number of words per sentence = 20.6 and grade level = 11.4. 
Table 2. Post Intervention Sample Demographics 
Variable Sample  % (n) 
Annual Income 
Less than $25,000            
$25,001-$50,000 
$50,001-$75,000 
$75,001-$100,000 
More than $100,000                                               
 
 
   20% (1) 
   40% (2) 
   20% (1) 
   20% (1) 
     0% (0) 
Highest Educational Level 
 
 0-8 years                      
 9-12 years                        
 High School/GED                            
 1-2 yrs. College           
 4 yrs. College             
 
 
     0% (0) 
   40% (2) 
     0% (0) 
     0% (0) 
   60% (3) 
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Sample Demographics 
 An independent-samples t-test was conducted to compare the mean ages between the 
pre and post-intervention groups. There was no significant difference in mean age for the pre 
intervention group (M = 66.67, SD = 17.35) and post intervention group (M = 75.80, SD = 8.70; t 
(13.76) = -1.61, p =.27). Cross-tabulations were performed to compare pre and post intervention 
groups with history of research participation. A Chi-square test for independence indicated no 
significant difference between pre and post intervention groups and history of research 
participation, X
2
 (1, n = 23) = .24, p = .62. A Chi-square test for independence indicated no 
significant difference between pre and post intervention groups and income, X
2 
(1, n = 23) = .96, 
p =.91). A Chi-square test for independence indicated no significant difference between pre and 
post intervention groups and level of education, X
2
 (1, n = 23) = .86, = p =.35).  
Quality of Informed Consent  
The mean score on Part A was 68.45 (SD = 5.71). See Figure 4 for all mean scores by 
domain. One area of notable misunderstanding was found in Domain 11, the domain related to 
compensation for research-related injury, where 40% (n = 2) of participants answered correctly, 
while 60% (n = 3) were either unsure or answered incorrectly. The groups’ mean score was 60 
(SD = 41.83). 
Another problematic area came in Domain 4, procedures to be followed. This domain is 
measured by two questions. For the first question 40% of participants answered correctly, 60% 
unsure. For the second question, no one answered correctly, 60% were unsure and 40% answered 
incorrectly. Here the mean score was 45.0 (SD = 11.18). For the post-intervention group, study 
procedures included a telephone or office visit at approximately 90 days, 180 days, 356 days, and 
450 days at which time participants’ medical status is evaluated. This concept was also 
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problematic for the pre-intervention group. See Table 4 for all domains, concepts and 
percentages of correct responses.  
 
Figure 5. Post Intervention Group Mean Scores by Domain 
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Table 3. QuIC Domains, Concepts and Percentage Correct (n = 5) 
DHHS 
Element 
QuIC 
Domain 
Domain and Corresponding Concept of the Quality of Informed Consent Questions 
& 
 % Correct 
1 Domain 1 
 
A statement that the study involves research 
 
A1 = 100% 
1 Domain 2 
 
An explanation of the purposes of the research 
 
A2 = 80% 
A5 = 80% 
 
1 
 
Domain 3 
 
 
The expected duration of the subject’s participation 
 
 
A3 =100% 
1 Domain 4 
 
A description of the procedures to be followed 
 
A10 =40% 
A11 = 0% 
 
1 
 
Domain 5 
 
 
Identification of any procedures that are experimental 
 
 
A4 =100% 
2 Domain 6 
 
A description of any reasonably foreseeable risks or discomforts to the 
subject 
A12 = 0% 
 
3 
 
Domain 7 
 
 
A description of any benefits to the subject that may be expected from the 
research 
 
A9 = 0% 
A13 =80% 
 
3 
 
Domain 8 
 
 
A description of any benefits to others that may be expected from the 
research 
 
A14 = 
100% 
 
 
4 
 
Domain 9 
 
 
A disclosure of appropriate alternative procedures or courses of treatment, 
if any, that might be advantageous to the subject 
 
A16 =20% 
 
5 
 
Domain 10 
 
 
A statement describing the extent, if any, to which confidentiality of 
records identifying the subject will be maintained 
 
A15 = 
100% 
6 Domain 11  
 
For research involving more than minimal risk, an explanation as to 
whether any compensation and/or any medical treatments are available if 
injury occurs, and if so, what they consist of and where further information 
may be obtained. 
A17 = 0% 
 
7 
 
Domain 12 
 
 
An explanation of whom to contact for answers to questions about the 
research, research subjects’ rights and whom to contact in the event of a 
research-related injury to the subject 
 
A18 = 
100%  
 
8 
 
Domain 13 
 
 
A statement that participation is voluntary, refusal to participate will 
involve loss of benefits to which the subject is otherwise entitled, and the 
subject may discontinue participation at any time without penalty or loss of 
benefits to which the subject is otherwise entitled 
 
A19 = 
100% 
A20 =80% 
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Figure 6. Pre and Post Intervention Mean Scores by Domain. 
 An independent-samples t-test was conducted to compare the mean scores on Part B of 
the QuIC between the pre and post-intervention groups. There was no significant difference in 
scores for the pre intervention group (M = 88.72, SD = 12.0) and the post intervention group  
(M = 80.28, SD = 23.65; t (21) = 1.11, p = .27). Based on previous research it is not surprising to 
see higher scores on Part B than Part A. The post-intervention group results demonstrated the 
same areas or concepts of misunderstanding as the pre-intervention group. See Figure 4 for mean 
scores for both the pre and post-intervention groups. The results of this sample also demonstrated 
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Table 4. Individual Mean Scores and Standard Deviations on 
the QuIC Part A Compared to Mean Scores on Part B 
Participant 
Number 
Part A Mean and 
(Standard Deviation) 
Part B Mean and 
Standard Deviation 
1      69.23 (43.49)      40.00 (24.81) 
2      71.15 (37.98)      87.14 (16.84) 
3      75.00 (35.36)      80.00 (28.28) 
4      59.61 (42.74)      97.14 (7.26) 
5      67.30 (42.55)      97.14 (7.26) 
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poor understanding of research-related injury compensation and procedures to follow, again, an 
unexpected finding not found in the literature.  
Primary Analyses 
The primary research question to be answered by this study was “In research participants, 
will the use of the teach back process of communication improve objective understanding of 
informed consent?” To answer this question an independent samples t-test was conducted to 
compare the mean scores on Part A (objective understanding) of the QuIC between the pre and 
post-intervention groups. There was no significant difference in mean objective understanding 
score between the pre intervention group (M = 75.44, SD = 12.85) and the post intervention 
group (M = 68.43, SD = 5.74; t (21 = 1.17, p = .057).  
The second research question in this study was, “In research participants, is the 
relationship between objective and subjective understanding different in the control group 
(standard communication) compared to the experimental group (teach back communication?)” 
To answer this research question an independent samples t-test was conducted to compare the 
differences between objective and subjective understanding in the pre-intervention group to the 
post intervention groups. There was no significant difference on the mean difference between 
objective and subjective understanding between the pre-intervention group (M = 13.31, SD = 
13.9) and the post intervention group (M = 11.82, SD = 25.1; t (21) = .174, p = .85. 
Additional Analyses 
 Another step in the analyses was to examine what if any impact participants’ 
educational level had on research comprehension. Cross-tabulations were conducted with highest 
educational level obtained and concepts that were problematic for both groups by examining 
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specific questions on the QuIC. Highest educational level obtained were categorized into less 
than high school (n = 6) and high school or higher (n = 17).  
 Question A4 measures understanding of procedures that are experimental. Both groups 
had a poor understanding of this concept. There was no significant association between 
educational level and understanding of experimental procedures,  X
2
 (2, n = 23) = 2.99, p = .22. 
 Cross-tabulations were conducted for the categorical variables of educational level with 
questions related to procedures to follow (Domain 4). A Chi-square test for independence 
indicated no significant association between highest educational level obtained and answers to 
question A10, one question in Domain 4, procedures to follow, X
2
 (2, n = 23) = 3.03, p = .21. 
The same non-significant association was found with the second question, A11 in Domain 4, X
2
 
(2, n = 23) = 1.95, p = .37. Results for question A12, potential risks, also demonstrated no 
significant association with highest educational level obtained and understanding of potential 
risks, X
2
, (2, n = 23) = 2.25, p = .32.  
 An understanding of benefits to self, as opposed to benefits for future patients are 
captured in Domain 7 by answering questions A9 and A13 on the QuIC. A Chi-square test of 
independence demonstrated no significant association between highest educational level 
obtained and benefits to self on question A9, X
2
 (2, n = 23) = 1.95, p = .37, nor was there an 
association on question A13, X
2
 (2, n = 23) = 3.55, p = .16. 
 The same procedures were performed to examine an association with highest 
educational level obtained and the answer on the QuIC that measures understanding of 
compensation for research-related injury, A17. A Chi-square test for independence indicated no 
significant association between highest educational level obtained and understanding of 
compensation for research-related injury, X
2
 (2, n = 23) = 1.15, p = .56. While further statistical 
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analyses is limited due to the small sample size, these results demonstrate that having a higher 
education has no impact on understanding key concepts within the consent form and/or during 
the consenting process thus making comprehension difficult for all. This may be useful for 
investigators and research coordinators to understand as one should not assume that a more 
highly educated participant has a higher likelihood of understanding.  
  The final covariate in this study was the reading level of the informed consent 
document. This would have been a valuable covariate to analyze if there had been multiple 
consent documents read by these participants, however, only two consent forms were used for all 
participants. The Flesch-Kincaid reading level of the informed consent forms were 10.5 and 11.4 
for pre and post intervention groups respectively both of which are greater than the 
recommended eighth grade level. 
Descriptive statistics and frequencies were run on the pre-intervention group only and 
cultivated into a manuscript for the journal IRB: Ethics & Human Research. This journal was 
chosen because it is a peer-reviewed journal whose primary focus is ethical and policy related 
issues of human subjects’ research, including results of empirical studies. The manuscript will 
focus on pre-intervention data analysis with a focus on findings from this study not seen in the 
literature and discuss any progress made to date on improvements for participants’ 
understanding. In the manuscript the “sample” refers to this study’s pre-intervention group. The 
manuscript will be formatted per the journal’s requirements prior to submission. 
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Abstract 
United States federal regulations requires investigators obtaining informed consent for  
research provide potential participants with information in a language and reading level easily 
understandable for them. Despite this, it is common for consent forms to be written at a graduate 
level. Previous studies have concluded that research participants’ do not understand basic 
concepts of their clinical trial such as randomization, risks and benefits.  
Thirty-eight cardiac clinical trial participants were mailed the Quality of Informed 
Consent survey and a demographic form following their agreement to participate in their trial. 
Eighteen surveys were returned for a response rate of 47%. Results demonstrate a poor 
understanding of what procedures needed to be followed in their clinical trial and potential 
compensation should they sustain a research-related injury. This report describes unexpected 
findings not reported in the literature to date, discusses any progress made on improvements for 
participants’ understanding and suggestions for future research. 
 
Key words: Clinical trials, compensation, participants’ understanding, research-related injury, 
risks 
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Introduction 
United States federal regulations requires investigators obtaining informed consent for 
research provide potential participants with information in a language and reading level easily 
understandable for them (Code of Federal Regulations, 2012). Despite this, it is common for 
consent forms to be written at a graduate level. There is a body of knowledge demonstrating that 
research participants have significant misunderstandings about the potential benefits, risks and 
experimental nature of their research study (Barrett, 2005; Flory & Emanuel, 2004; Hietanen, 
Aro, Holli, Schreck, Peura, & Joensuu, 2007; Jefford et al., 2010; Joffe, Cook, Cleary, Clark, & 
Weeks, 2001; Schwartz & Appelbaum, 2008). Seventy-five percent of the public reports they 
have little or no knowledge of clinical research or the participation process (Getz, 2007). This 
issue compounds the problem faced by investigators obtaining consent for research participation 
where many of the concepts required by federal regulations may be foreign to most of the public.  
Background 
In 2003, the National Center for Education Statistics (NCES) surveyed the American 
adult population to ascertain English language literacy skills. Results demonstrated that 75 
million Americans (36%) have basic or below-basic health literacy (National Center for 
Education Statistics, 2003).  Currently, approximately forty seven percent of Americans, 
roughly, 90 million, have difficulties understanding health information given to them by their 
providers (Wilson, 2009). It has been documented that patients absorb and recall only about half 
of what physicians have communicated to them (Schillinger et al., 2003). In addition, 
approximately forty to eighty percent of medical information is forgotten almost immediately 
with the greater the information being given proportional to the amount of information forgotten 
(Kessels, 2003). 
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The purpose of this study was to assess cardiology research participants’ objective and 
subjective understanding of informed consent.   
Methods 
Research Design This study used a descriptive design.  
Setting 
This study drew its sample from a population of Cardiology clinical trial participants in a 
large, tertiary, acute care hospital in New England. This 600 + bed hospital is the major referral 
center for cardiology patients in the state where procedures include pacemaker implants, 
coronary artery bypass surgery, balloon angioplasty, robotic mitral valve replacement, trans-
catheter aortic valve replacement and open heart surgery. At the organization where this study 
was conducted, there are 3 Clinical Research Coordinators in the department of cardiology that 
are responsible for the oversight and conduct of clinical research including obtaining informed 
consent.  
Sample 
The study used a convenience sample of cardiology clinical trial participants. Inclusion 
criteria included English speaking and writing and enrolled in a cardiac clinical trial. Exclusion 
criteria included anyone under the age of 18 years, patients with a current diagnosis of dementia, 
Alzheimer’s or who are otherwise cognitively impaired or diagnosed with a mental illness, or 
participation in a research study where assent was given by a legal guardian or someone other 
than the participant themselves.  
Measurement 
Quality of Informed Consent. The Quality of Informed Consent (QuIC) instrument 
developed by Joffe et al. (2001) started with the basic elements of informed consent outlined in 
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federal regulations (Code of Federal Regulations, 2012). These include elements such as the 
voluntary nature of the research, the risks and benefits, the use of Protected Health Information, 
the cost to the participant as well as other key points that are required to be in the consent form. 
The overall purpose of the instrument was to evaluate participants’ understanding of their 
clinical trial. Part A of the QuIC measures objective understanding, what participants’ actually 
understand. Part B of the instrument measures subjective understanding which assesses what 
participants believe they understand (Joffe et al. 2001). Some of the elements such as “potential 
benefits” may actually be two different concepts i.e. benefits to self and benefits to future 
patients. Therefore the questions on the survey are composed of 13 independent domains (Joffe 
et al., 2001). (Table 4). The QuIC contains 20 questions in 13 domains in Part A answered on a 
Likert scale from 1 (disagree), 2 (unsure) and 3 (agree). Each correct answer in Part A is given a 
score of 100 points, an “Unsure” response is given a score of 50 points and incorrect answers are 
given 0 points. Unanswered questions are not scored.  
Part B of the instrument contains fourteen questions answered on a Likert scale from 1 (I 
didn’t understand this at all) to 5 (I understood this very well). Part B of the QuIC is scored by 
taking the average responses to each of the fourteen questions and scaled from 0-100 (summary 
score = raw average -1 x 25). This allows for equal weighting among the domains in the 
instrument. The QuIC is written at 8th grade reading level. The interclass correlation coefficient 
(ICC) was .66. It was noted that subjects with lower scores had greater test–retest variability than 
those with higher scores. Part A of the QuIC instrument had a mean score of 76 and Part B 
summary scores averaged 87.2 and the interclass coefficient was .77 during pilot testing of the 
instrument (Joffe et al., 2001). Permission to use the QuIC was obtained from the author.
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Procedures 
This study received approval from the Institutional Review Board (IRB) at the university 
where the primary author is a student and the participating hospital. A study packet containing a 
cover letter, demographic information sheet and the Quality of Informed Consent (QuIC) survey 
were mailed to a convenience sample of 38 cardiac clinical trial participants. Two weeks 
following the mailed surveys a reminder postcard was mailed to the same participants to increase 
the response rate (Dillman, 1991).  A total of 18 surveys were returned (47% response rate). All 
data were entered into the Statistical Package for the Social Sciences (SPSS) v. 22.  
Results 
Sample Demographics 
The sample included 12 males (67%) and 6 females (33%). Ages ranged from 36-84 
years with a mean age of 66.6 years (SD = 17.35). See Table 4 for other sample demographics. 
The Flesch-Kincaid readability statistics for the cardiac clinical trial consent form signed by this 
cohort included the following: number of pages = 15, number of words = 5115, average number 
of words per sentence 19.1, and grade level 10.5. 
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Results of QuIC Part A 
The total scores on the QuIC Part A (objective understanding) ranged from 55.76 to 
96.15 out of a possible 100 with a mean score of 75.44 (SD = 12.86). See Table 4 for QuIC 
domains, concepts and percentage correct.  
One area of misunderstanding was that of an explanation as to whether any compensation 
and an explanation as to whether any medical treatments are available if injury occurs, and if so, 
what they are and where to access further information. This concept is captured in Domain 11. 
Fifty percent of respondents answered this question correctly while the remaining 50% were 
either unsure or answered incorrectly. Here the mean score was 69.0 (SD = 35.93) with a range 
of scores from 0-100. 
 
 
 
 
Table 5. Sample Demographics 
Variable Sample  % (n) 
Annual Income 
Less than $25,000            
$25,001-$50,000 
$50,001-$75,000 
$75,001-$100,000 
More than $100,001                                               
 
 
12% (2) 
35% (6) 
35% (6) 
12% (2) 
6% (1) 
Highest Educational Level 
 
0-8 years                      
9-12yrs                        
High School/GED                            
1-2 yrs. College           
4 yrs. College             
 
 
11% (2) 
17% (3) 
22% (4) 
17% (3) 
33% (6) 
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Other difficulties in understanding the concepts within the informed consent were found 
in Domain 4, (see Table 4), a description of the procedures to be followed. This domain includes 
Table 6. QuIC Domains, Concepts and Percentage Correct (n = 18)   
DHHS 
Element 
QuIC  
Domain  
Domain and Corresponding Concept of the Quality of Informed 
Consent 
Questions & 
% Correct 
1 Domain 1 
 
A statement that the study involves research  A1 =100% 
1 Domain 2 
 
An explanation of the purposes of the research 
 
A2 =100% 
A5 = 100% 
 
1 
 
Domain 3 
 
 
The expected duration of the subject’s participation 
 
 
A3 = 83% 
1 Domain 4 
 
A description of the procedures to be followed 
 
A10 =56% 
A11 = 78% 
 
1 
 
Domain 5 
 
 
Identification of any procedures that are experimental 
 
 
A4 = 6% 
2 Domain 6 
 
A description of any foreseeable risks or to the subject A12 = 22% 
3 Domain 7 
 
A description of any benefits to the subject that may reasonably be 
expected from the research 
A9 = 22% 
A13 = 89% 
 
3 
 
Domain 8 
 
 
A description of any benefits to others that may reasonably be 
expected from the research 
 
A14 =100% 
 
4 
 
Domain 9 
 
 
A disclosure of appropriate alternative procedures or courses of 
treatment, if any, that might be advantageous to the subject 
 
A16 = 72% 
5  
Domain 10 
 
 
A statement describing the extent to which confidentiality of 
records identifying the subject will be maintained 
 
A15 = 78% 
 
6 
 
Domain 11  
 
 
An explanation as to whether any compensation and/or medical 
treatments are available if injury occurs, and if so, what they 
consist of and where further information may be obtained. 
 
A17 = 50% 
 
7 
 
Domain 12 
 
 
An explanation of whom to contact for answers to questions about 
the research, research subjects’ rights and whom to contact in the 
event of a research-related injury to the subject 
 
A18 = 76% 
 
8 
 
Domain 13 
 
 
A statement that participation is voluntary, refusal to participate 
will involve no loss of benefits to which the subject is otherwise 
entitled, and the subject may discontinue participation at any time 
without penalty or loss of benefits to which the subject is 
otherwise entitled 
 
A19 = 100% 
A20 = 41% 
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two statements on the QuIC. Here, only 7 out of 18 participants (39%) answered correctly 
(scores ranged from 50-100 with a mean score of 78.0 (SD = 20.8). All participants in this 
sample were enrolled in the same randomized clinical trial. For their study this cohort of 
participants was randomized to receive or not receive a study envelope of antibiotic during 
surgery for placement of a Cardiovascular Implantable Electronic Device (CIED).  Study 
procedures included physician visit on the day of surgery and day of hospital discharge. 
Additional visits were required at 6 and 12 months post-surgery for the physician to monitor and 
download data from the device and participants to complete a health questionnaire. No other 
clinical trial procedures were required from the participants.  
All participants scored 100 on Domains 1, 2 and 8 answering all questions related to 
these domains correctly. These domains cover the concepts of research, purpose and potential 
benefit to others (future patients). See Figure 4 for Part A mean scores for all 13 domains.  
Part B scores ranged from 61.42 to 100 with a mean score of 88.73 (SD = 12.0). Only 
two respondents (11%) scored lower on Part B than their mean score on Part A. Table 4 shows 
the mean scores of Part A and Part B for all 18 respondents. Research has demonstrated that 
participants believe themselves to be informed, have asserted the information provided to them 
as easy to understand, but have demonstrated poor understanding (Hietanen et al., 2007). 
Therefore, higher mean scores on Part B of the QuIC, when compared to Part A were not 
unexpected. See Table 4 for a comparison of Part A and Part B mean scores. 
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Figure 7. Mean Scores by Domain  
 
Table 7. Individual Mean Scores and Standard Deviations on 
the QuIC Part A and Part B 
Participant 
Number 
Part A Mean and 
(Standard Deviation) 
Part B Mean and 
Standard Deviation 
1 96.15(13.87) 100.00(00.00) 
2 57.69(49.35) 75.71(32.51) 
3 79.16(38.19) 85.71(26.52) 
4 92.30(18.78) 84.28(13.99) 
5 69.23(39.73) 94.28(21.38) 
6  80.76(34.09) 97.14(10.69) 
7 55.76(37.02)   61.42(37.18) 
8  63.46(36.25)  95.71(8.52) 
9 65.38(36.14) 82.85(17.54) 
10 76.92(31.39)  61.42(37.18) 
11 84.61(29.82)  85.71(12.22) 
12 65.38(41.51)  97.14(10.69) 
13 75.00(38.19)  98.57(5.35) 
14 75.00(20.50) 92.85(12.67) 
15 65.38(42.74)  97.14(7.26) 
16 92.30(18.78)  95.71(8.52) 
17  96.15(13.87) 100.00(0.0)  
18 67.30(37.34)  91.42(12.92) 
100 100 
92 
78 
28 28 
72 
100 
75 
86 
69 
85 
76 
0
20
40
60
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Mean Score
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Discussion 
 
Interestingly, one concept poorly understood by participants was options for them 
should they sustain a research-related injury including who to call and whether or not they would 
be compensated. This domain is measured by the following question, “The consent form I signed 
describes who will pay for treatment if I am injured or become ill as a result of participation in 
this clinical trial.”  Fifty percent of participants were either unsure or did not know the correct 
answer to this question. This was an unexpected finding and not reported in the literature.  
What may be clear language in an informed consent document to a healthcare 
professional is not always clear to a lay person. While consent forms may clearly state that 
research-related injury will not be paid for by the study’s sponsor, it does not tell potential 
participants that it is against United States (U.S.) federal regulations to pay for treatment of 
research injuries. In fact, no agency within the U.S. federal health system has a formal 
compensation policy for research injuries (Hochauser, 2004). Although medical care for 
research-related injuries is mandatory, institutions are not required to provide compensation. 
Adding to the problem is the difficulties in determining if a medical illness or injury are related 
to the research, particularly if they occur several months later or if the patient has other illnesses 
and/or co-morbidities (Steinbrook, 2006).  
There is much debate on whether compensation to participants for a research-related 
injury should be mandated or not. On one side there is the argument that sponsors and 
institutions are ethically obligated to provide compensation for a research-related injury. The 
other side of the argument is that compensation should not be provided because participants 
understand the potential risks of their study when enrolling and signing informed consent 
(Steinbrook, 2006). The results of this study would dispute this as participants’ demonstrated a 
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lack of understanding of potential risks. This finding is also supported by previous studies. This 
debate continues today, but does beg the question of participants’ understanding of risks and any 
compensation to which they may be entitled. This also raises the ethical issues for patients 
participating in clinical trials who do not have insurance and would therefore have no medical 
coverage should they sustain an illness or injury as a direct result of their research participation. 
If an un-insured research participant were to sustain an injury as a direct result of the clinical trial 
participation, the financial ramifications may be numerous and therefore pose an unduly fair 
burden to the participant.  
The difficulty in understanding of procedures to be followed is cause for concern as 
only 39% of the sample understood this. The misunderstanding of this concept is also not 
described in the literature. One might wonder if participants’ clearly understood what procedures 
they needed to follow in their clinical trial, might they still consent to participate. Additionally, if 
trial-specific procedures are not clearly understood and followed by participants accuracy of trial 
data may be jeopardized and/or protocol deviations may occur. For this cohort their clinical trial 
procedures included physician office visits and the completion of a health questionnaire. If 
participants missed any office appointment and/or the completion of the health questionnaire 
they received a phone call from the research coordinator in order to remain compliant with the 
protocol and collect the required data. For other clinical trials that may have more complex 
procedures to be followed such as certain dosing of medications or time-specific laboratory 
draws a lack of understanding of specific procedures to follow is very concerning.  
Participants continue to fail to understand the critical differences between standard care 
and experimental procedures (Brody, Dalen, Annett, Scherer, & Turner, 2011). This was evident 
in the current study where 94% of participants were either unsure or did not understand this 
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concept. The domains covering procedures that are experimental and risks to subjects were also 
poorly understood and not surprising.  Underestimating risks is a concept termed “therapeutic 
misestimation.” In a study by Pentz et al. (2012) as many as 94% of the study sample of 
Oncology clinical trial enrollees misestimated risk and benefit when asked. Most of the 
misestimations were overestimations of potential benefit to themselves. When participants were 
asked their motivation for enrolling into the clinical trial, 76% of patients had direct medical 
benefit as at least one of several reasons for entering the trial (Pentz et al., 2012). Some 
investigators have argued that patients who participate in research and understand their clinical 
trial is not designed for their personal benefit, may still express high expectations of therapeutic 
benefit but may not be suffering from therapeutic misconception, rather therapeutic optimism 
(Horng & Grady, 2003; Sulmasey, Astrow, He, Seils, Meropol, Micco, & Weinfurt, 2010). 
Based upon the results of this study it is especially important for clinicians and research 
coordinators obtaining consent for clinical trial participation to focus on areas that may be 
particularly problematic for participants to understand, especially the concepts of procedures to 
follow and compensation for injury. It is recommended that members of the research team, other 
than the physician treating the patient obtain consent to avoid further confusion between standard 
and experimental care. Informed consent is an ongoing process and assessment of participant 
understanding should not end once the informed consent document is signed. Additionally some 
standardized method for evaluating participants’ understanding needs to be implemented in order 
to clarify any misconceptions. Currently, there is no standardized process in place. Perhaps this 
will occur only if regulations mandate it. 
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Limitations 
There are a few limitations to this research that need to be acknowledged. The first 
limitation is the small sample size. The second limitation is that participants’ were asked to recall 
the informed consent process in order to answer the questions on the QuIC. The concept of recall 
refers to a function of memory which is different from that of understanding (Dunn & Jeste, 
2001; Falagas, Korbila, Giannopoulou, Kondilis, & Peppas, 2009).  Therefore, there is the 
potential for recall bias from the participants. Lastly, two surveys had data missing not at 
random. Interestingly the missing question on both surveys was the question regarding 
compensation for injury. Data missing not at random may result in bias. 
Conclusion 
 This study adds to the current body of knowledge by uncovering two unexpected 
findings of poor understanding of compensation for a research-related injury and clinical trial 
procedures to be followed. As early as 2003, the Institute of Medicine (IOM) recommended 
institutions conducting research compensate research participants who are injured as a direct 
result of participating in research, regardless of fault (Institute of Medicine, 2003). One argument 
regulatory bodies and bioethics committees have taken regarding compensation is the lack of 
quantifiable data on the number, severity, type and costs of research-related injuries (Federman, 
Hanna & Rodriguez, 2003; Henry, 2013; Steinbrook, 2006). The issue of whether or not to 
compensate participants should they become injured as a direct result of their clinical trial 
participation remains unresolved.  
 If participants continue to view themselves as informed, as prior research has suggested, 
a mixed-methods study employing both the QuIC questionnaire and targeted questions via 
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individual interviews to glean understanding, clarify misunderstandings and gather both 
inductive and deductive data may yield some interesting results.  
 Based upon the results of this study and other studies, research participants’ 
misunderstanding of key concepts related to their clinical trial continues to be problematic. It is 
suggested that future research be conducted to test the teach back method with this cohort, enroll 
a larger sample and address the limitations in this and other studies. Additionally, more studies 
are needed to capture data on research-related injuries. The volume, extent and costs of those 
injuries need to be quantified in order to obtain data to guide policy development.  
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Chapter Summary 
 The results of this study indicated there was no statistically significant difference in 
objective understanding between the pre and post intervention groups. Additionally, there was no 
significant differences between objective and subjective understanding in the two groups. 
Therefore the null hypotheses cannot be rejected. The reader is should interpret these findings 
with caution due to the small sample size.  
 Two important areas for informed consent mandated by United States regulations are 
what procedures to follow and compensation for a research-related injury. The results of this 
study demonstrated poor understanding of these two concepts not reported in the literature and 
therefore added to the current body of knowledge on this topic. Misunderstanding of other 
concepts such as potential risks, benefits and a distinction between experimental care and 
standard care are also evident in this study and support the literature. Additionally, having a 
higher education did not show an association with better understanding of other key concepts 
such as risks, benefits to self, experimental procedures, procedures to follow and research-related 
injury compensation.   
 The following chapter includes a description of major findings from the study, a 
discussion of study limitations and implications for nursing, policy and research.  
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CHAPTER 5 SYNTHESIS 
This chapter includes a discussion of the major findings from the study, study limitations 
and implications for nursing, policy and research.   
Major Findings from the Study 
There was no statistically significant improvement in objective understanding of 
informed consent for the post intervention group. It was hypothesized that the teach back method 
of communication would decrease the noise as described in the theoretical framework supporting 
this study (Shannon & Weaver, 1948). This would be achieved by the research coordinator 
(sender) simplifying the language from medical and legal terminology into lay language during 
the consenting process where the participant (receiver) would teach back the content during the 
feedback loop, allowing for clarification of any misunderstandings.  
Despite the challenges this study encountered the data analysis yielded interesting 
findings. Two specific findings from this study were unexpected as they are not reported in the 
literature. One unexpected finding was participants’ lack of understanding on whether or not they 
are entitled to compensation for a research-related injury. This was evident in both the pre and 
post-intervention groups. Understanding of this concept is captured in Domain 11. Additionally, 
participants did not understand clinical trial procedures to follow per responses found in Domain 
4. The lack of understanding of these two concepts was evident in both the pre and post-
intervention groups.  
 Research-related injury and possible compensation are one of the elements required to be 
disclosed during the informed consent process and included in the informed consent document. 
Federal regulatory bodies and bioethics committees have debated the ethics of providing 
research-related injury compensation to participants of clinical trials. Some argue that 
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participants freely volunteer to enroll into clinical trials fully aware of any potential risks. 
Compounding the problem is the difficulty in determining if an injury or illness has occurred as a 
direct result of the clinical trial due to participants overall health, age, and other co-morbidities 
they may have. This makes an accurate assessment of causality challenging. Others disagree 
stating that providing financial compensation for a research-related injury would be the ethical 
thing to do. It is not safe to assume that all participants are covered through Medicare, Medicaid 
or private insurance and for those trial participants who do become injured as a result of their 
research participation and have no health care coverage would incur a significant financial 
burden. The lack of understanding of this concept is not reported in the literature and was an 
unexpected finding in this study.  
For the pre-intervention group, clinical trial procedures included physician visits both in 
and out-patient and the periodic completion of a health questionnaire at specifically timed 
intervals. No other procedures were required from this group. For the post-intervention group, 
study procedures included a telephone or office visit at approximately 90 days, 180 days, 356 
days, and 450 days at which time participants’ medical status is evaluated.  
While these procedures seem straightforward, the overall mental and physical health of 
participants and whether or not that had any bearing on results is unknown. A poor 
understanding of clinical trial procedures could potentially lead to poor quality data or protocol 
deviations if not strictly followed. These two finding add to the body of science on what is 
currently known about research participants’ understanding of informed consent and merits 
further exploration.  
Research participants’ poor understanding of which procedures are standard care versus 
experimental, benefits to self and potential risks of the study were also apparent in this study for 
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both pre and post-intervention groups.  A lack of understanding of these 3 concepts has been 
identified for more than 20 years.  
 Finally, these results demonstrate that having a higher education had no impact on 
understanding key concepts within the consent form and/or during the consenting process thus 
making comprehension difficult for all. This may be useful for investigators and research 
coordinators to understand as one should not assume that a more highly educated participant has 
a higher likelihood of understanding.  
Research has also demonstrated the longer the consent form the increase in difficulties 
with comprehension (Mann, 1994). The Flesch-Kincaid statistics of the informed consent 
document for the pre-intervention group was a reading level of 10.5, 15 pages in length and 
contained 5115 words. For the post intervention group, the informed consent document had a 
reading grade level of 11.4, was 13 pages long and contained 4179 words. This may or may not 
have had any bearing on the participants’ level of understanding but is clearly over the desired 
eighth grade reading level. 
Many studies have attempted to test interventions to improve informed consent 
understanding but have mixed results as reported in Chapter 2. Despite the plethora of research 
describing clinical trial participants’ poor understanding of key concepts of their study, and many 
various interventions attempting to make improvements in understanding the issue persists.  
Study Challenges 
This study was fraught with many site-specific challenges which ultimately lead to a 
change in the research design and data analysis. One of the challenges for this study was the 
student Principle Investigator not being an employee where the study took place. Not being 
embedded within the organization lead to a heightened sense of mistrust from one coordinator. 
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Despite best efforts to clarify confusion as to the purpose of the study, there was a general sense 
from the coordinators that evaluating participants’ understanding may be a reflection on their 
capabilities to provide informed consent and therefore they were somewhat reluctant to offer 
their support. The research coordinators also declined to informed consent observations which, if 
completed would have added internal validity to the study. The director of cardiology was a key 
stakeholder and instrumental in the success of the study, however, communication with was 
challenging and his time very limited. Despite his being supportive of this study, his managerial 
style was very much hands-off allowing the coordinators to control and direct the flow of the 
study.  Despite the many barriers the study was completed. Interesting the data yielded some 
unexpected results, not widely reported in the literature.  
Limitations 
 The major limitation to this study was the sample size. Study challenges prevented data 
collection on the desired sample size determined a priori to the conduct of this study, despite 
many strategies at attempting to increase participation. Statistical analyses were conducted as 
planned to answer the primary research questions however results may reflect that of a Type II 
error. The small sample size increases the likelihood of concluding that the experimental 
intervention does not differ from the control, therefore power of the study may be inadequate 
(Guyatt, Jaeschke, Heddle, Cook, Shannon, & Walter, 1995). “The likelihood of missing an 
important difference (and making a Type II error) decreases as the sample gets larger” (Guyatt et 
al., 1995, p. 27). 
 Limitations to this study also include the quasi-experimental design. Ideally, 
randomization of the sample would have added scientific rigor to the study but was impractical 
given the clinical setting of the study. The ability to explain the effect of interventions or changes 
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that may have occurred simultaneous to the study intervention is limited with pre-post study 
designs. Bias can arise when nurses know that their performance and the impact of a practice 
change are being monitored for research purposes. It may be possible that the research 
coordinators’ behavior changed when consenting participants as they were not blinded to the 
study’s aim and intervention. Another limitation is the potential for recall bias from participants. 
The final limitation was the inability to observe the consenting process. Observations of the 
communication methods used by the coordinators, that of standard communication or teach back 
would have added internal validity to the study.  
Implications for Nursing 
Given the relocation of clinical trials from academic medical centers to community 
settings, nurses need to be cognizant of the functions related to clinical trials. Whatever the 
clinical setting, nurses are increasingly likely to confront patients who are participating in a 
clinical trial (Parreco, Ness, Galassi, & O’Mara, 2012). Therefore, nurses working in a variety of 
settings need to be knowledgeable about the regulatory requirements of informed consent and be 
able to answer patients’ questions, even broadly about their clinical trial. To increase clinical 
nurses’ awareness of this issue, in 2011, the journal, American Nurse Today published a four-
part series discussing what clinical nurses need to know when taking care of patients enrolled in 
a clinical trial.  
As much as 80% of medical errors are attributed to miscommunication among 
caregivers (American Nurses Association, 2012). This is echoed by The Joint Commission who 
states that poor communication was the root cause 65-70% of the time when analyzing more than 
3000 sentinel events from 1995-2005 (Adamski, 2007). Nurses providing education and 
information to patients need to be aware of the patients’ health literacy, functional ability and 
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capacity to understand. It is not uncommon to ask patients if they have any questions which does 
not provide for an accurate assessment of understanding. Teach back method of communication 
assesses patient understanding and allows for corrections of information as needed. Teach back 
communication takes training and practice, not universally available to many nurses today. The 
Institute of Medicine reports that “if health professionals were able to take the time to ask their 
patients to explain exactly what they understand about their diagnosis,  instructions and bottle 
labels, the caregivers would find many gaps in knowledge, difficulties in understanding and 
misinterpretations” (Institute of Medicine, 2004, P. XI). 
One provision of the Affordable Care Act is the implementation of shared decision-
making. While this may be a strong recommendation few policies are available to guide practical 
application (Maughn et al., 2016). It has been suggested that the practical application of shared 
decision making may include the use of  patient decision aids such as  written materials, videos, 
or interactive electronic aids, all of which are intended to inform patients and their families about 
treatment options (Lee & Emanuel, 2013). Nurses, as frontline clinicians are well positioned to 
embrace shared-decision making as they will play a pivotal role in patient education and with 
training in communication techniques designed to improve understanding, could take an early 
lead on this initiative.  
Implications for Policy 
One of the major ethical principles guiding research conduct with human subjects as 
outlined in the Belmont Report is the principle of respect which honors individuals’ right to 
choice (National Commission for Protection of Human Subjects of Biomedical and Behavioral 
Research, 1979).  Working within this principle, investigators are required to provide a consent 
process to potential research participants with sufficient knowledge and understanding of 
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research for informed decision making (Whitney, 2001). Despite this, it is common practice for 
physicians, investigators, research coordinators and others obtaining informed consent to not 
verify participants’ understanding. The Office of Human Research Protection (OHRP) offers 
little guidance on how to obtain consent, but rather is instructive on regulatory requirements 
only.  
The Code of Federal Regulations (2017) has recently been revised to improve 
participants’ ease with decision-making and includes alterations to the requirements for informed 
consent relating to the content, organization, and presentation of information included in the 
consent form. These changes occurred as a result of studies claiming consent forms have 
significantly lengthened, become more complex and appear to be designed to protect institutions 
rather than to provide potential research participants with the most important information needed 
to make an informed decision (Beardsley et al., 2007; Code of Federal Regulations, 2017; 
Levine, 1991). Part of the organizational changes to the consent form mandate the eight required 
elements be disclosed first and all other information be added as appendices. It is the hope that 
this “core” of the consent form will provide clear concise information to potential participants in 
one location rather than having the required elements buried in other medical and legal verbiage 
throughout the document (Code of Federal Regulations, 2017). These new regulations will 
become effective in 2018 and therefore it remains to be seen whether these will lead to 
improvements in participants’ understanding. Given the plethora of research demonstrating poor 
comprehension it would behoove researchers to apply the new recommendations now rather than 
wait until they become legally required.  
The findings from this study warrant dissemination among Institutional Review Boards 
(IRBs) across the private and public sectors. IRBs are charged with the protection of human 
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subjects and are therefore key players in mandating informed consent documents be written and 
formatted in an easily understandable style and have the authority to request such changes prior 
to approval. IRBs and research compliance programs across healthcare and academic settings 
need to develop policies and protocols as guidance for investigators including templates using 
plain language.  Research compliance programs need to be established that will develop quality 
improvement initiatives on informed consent such as follow-up inquiries with participants 
regarding their comprehension of the eight required elements.  
Additionally, the Society of Clinical Research Association (SOCRA) and the Association 
of Research Professionals (ACRP), two national organizations certifying registered nurses as 
research professionals do not have a policy or regulatory requirement for competency in 
obtaining informed consent, nor verifying participants’ understanding.  
The impetus for this research study was born from a descriptive study previously 
conducted by the student Principal Investigator examining participants’ understanding of 
research consent (Palmer & Trott, 2013). The descriptive study was conducted as a quality 
improvement initiative as part of the organization’s application to achieve accreditation from the 
Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP). It 
was, at that time, a plan to develop a comprehensive program for the organization’s research 
coordinators and other investigators to demonstrate competency in obtaining consent for research 
participation. This program would include a policy for developing competency in consenting and 
incorporate teach back communication as a method to assess for understanding. More policies 
from organizations’ Institutional Review Boards and the national level could mandate some 
method for investigators to verify potential participants’ understanding. 
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Medical care is designed to provide individual patients with the best treatments possible 
for their particular illness. Research, by contrast, has as its primary goal the creation of 
generalizable knowledge that may be of benefit to future patients. These different goals result in 
different relationships. Federal regulations require researchers to disclose potential harms of the 
research study, but researchers are not required to advise potential participants as to whether 
participation is in their best interests (Pike, 2012). “Some scholars argue that being a patient in a 
clinical care setting and a subject in a research study are so different that anything that would 
promote in subjects the view that they are in clinician-patient relationships is exploitative and 
deceptive” (Easter, Henderson, Davis, Churchill & King, 2006, p. 695). One solution to decrease 
confusion patients may have between standard care and experimental care would be to have a 
member of the research team other than the treating physician obtain research consent. Much of 
the literature suggests this practice but it is not mandated by federal regulations.  
To address the issue of therapeutic misconception the National Institutes of Health (NIH) 
created a forum to examine the issue and make recommendations (Henderson et al., 2007). A 
panel of experts was formed and identified 5 major areas of understanding determined necessary 
for an adequate comprehension of research in order for potential participants to distinguish 
health research from health care. These domains included a clear understanding that the scientific 
purpose of a study is designed to produce generalizable knowledge, research participation may 
involve study procedures intended only to generate scientific knowledge not necessary for 
patient care, the interventions studied in clinical research are based on less certainty about risks 
and benefits to a population than when a doctor prescribes standard treatments, treatments are 
based on a strict adherence to a protocol with defined doses and scheduling and clinicians as 
investigators presents physicians in dual roles that may confound the distinction between 
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treatment and research. Despite these noble efforts, little has actually changed in the practice of 
enrolling participants into clinical trials. 
Implications for Research 
Informed Consent  
Based on the unexpected results from this study, further research is needed to explore 
participants’ understanding of compensation for research-related injury. More research into 
participants’ understanding of this concept may determine whether this was problematic for this 
particular cohort or in fact, a more global issue. No studies to date have taken an inductive 
approach to glean participants’ understanding and therefore this method may provide valuable 
insights into the issue.  
Additionally, as some regulatory bodies have contended, studies are needed to quantify 
the volume of research-related injuries, the nature, extent and costs of those injuries to guide 
policy development.  “Despite the requirement to report serious adverse events to sponsors, 
Institutional Review Boards and regulatory authorities, there are few systems in place to quantify 
the severity, frequency and types of injuries and the associated costs of managing medical care or 
rehabilitation in any country” (Kang, 2012, p.78). Future policies cannot be developed to protect 
clinical trial participants in the event of a research-related injury until there is the science to 
inform clinical practice.  
Additionally, more studies are needed to glean rigorous data on clinical trial participants’ 
understanding of procedures to follow. A misunderstanding of this concept was evident in this 
study yet is not widely reported in the literature. More studies are needed to support or refute this 
finding. If other research supports this finding and it becomes apparent this is a problematic area 
for clinical trial participants, strategies will need to be developed and tested to improve 
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participant understanding of this concept. Without a clear understanding of clinical trial 
procedures autonomous and informed voluntary participation is jeopardized as well as clinical 
trial data and protocol adherence.  
Previous studies have agreed the concept of potential benefit associated with research 
participation is difficult for participants to understand (Joffe et al., 2001). Benefit for self, despite 
clear explanations from those conducting the consent is a concept originally described by 
Applebaum, Roth, Lidz, Benson, & Winslade (1987) as “therapeutic misconception” and is 
widely reported in the literature. “Unfortunately, therapeutic misconception has been used 
loosely to refer to any number of misunderstandings that subjects may have in the research 
context. This imprecise use of the term can itself cloud our assessment of when informed consent 
is compromised” (Horng & Grady, 2003, p.11). Jansen, Applebaum, Klein, Weinstein, Cook, 
Fogel, & Sulmasy (2011) suggests this may be a common occurrence, particularly in Oncology 
clinical trials. Exactly why participants may overestimate benefits and/or underestimate risks has 
been the topic of much discussion, yet remains unclear. The concept of unrealistic optimism 
needs further exploration.  
To date, the vast majority of studies examining research participants’ understanding have 
taken a deductive approach. Very few studies using inductive methods to glean participants’ 
understanding are reported. Qualitative approaches to explore this concept may provide 
interesting results and add to the current body of science on this important topic.  
This study could also build a comprehensive research program examining the issue of 
informed consent for surgery or other medical procedures. Informed consent for surgery, medical 
procedures not deemed research or in the construct of informed, autonomous shared decision-
making are still lacking in the literature.  
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Teach Back 
Teach back has demonstrated enhanced patient understanding leading to improved patient 
outcomes in a number of studies (Kornburger et al., 2013; Negarandeh et al., 2012, Peter, 
Robinson, Jordan, Lawrence, Casey, & Salas-Lopez, 2015). However, to date, only one study 
has empirically tested the teach back method in clinical trial participants (Kripalani et al., 2008). 
It is recommended that study be replicated with a larger sample of clinical trial participants. 
Further research is also recommended in other cohorts of clinical trial particiants, such as 
oncology where difficult and lengthy informed consent documents are common.  
Communication 
Patients have increased access to the internet and hospitals’ public reporting of core 
quality measures thus are more educated, informed consumers. Poor communication is the 
primary reason for filing a medical malpractice suit in more than 80% of cases (Avery, 1985). 
Weiss, Reed, & Kligman (1995) demonstrated that patients have difficulties understanding 
instructions given to them by their physicians. Additionally, healthcare practitioners overestimate 
their own effectiveness in communication and underestimate patients’ need for information 
(Schillinger, et al., 2003). Providers continue to use medical terminology, communicate too 
much to the patient causing information overload and do not routinely assess patient 
understanding (Kripalani & Weiss, 2006). Strategies to improve communication may diminish 
the number of litigious cases. However, to communicate effectively, nurses and other healthcare 
practitioners need to familiarize themselves with the issues involved in the communication 
process. Once there is an awareness of these issues plans can be made to analyze situations, solve 
problems, and make process improvements. The use of the Shannon Weaver theory will allow 
for this identification and analysis. According to Walker and Avant (2010) where there are 
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untested theoretical concepts it is prudent to test those relationships which will add to the body of 
knowledge. This communication theory would be an excellent framework for research regarding 
miscommunication during patient hand-offs as seen in the literature where shift report between 
nurses is often taking place in a busy, loud and distracting nurse’s station.  
Chapter and Dissertation Summary 
 Empirical studies assessing research participants’ understanding of informed consent 
have been seen in the literature for a number of years. This study tested the teach back 
communication method as an intervention to improve research participants’ understanding of 
informed consent and was supported by the Shannon Weaver communication theory. Many 
study site-specific challenges limited access to clinical trial participants resulting in a small 
sample size. Despite this the analyses demonstrated that participants in both the pre and post 
intervention groups had a poor understanding of compensation for research-related injury and 
clinical trial procedures to follow. These findings have not been previously reported in the 
literature. Targeted interventions need further assessment to develop appropriate methods to 
improve understandings and tackle the ethical issues of compensation for research-related 
injuries. 
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APPENDIX C 
 
Cover Letter 
 
 
To Whom It May Concern: 
 
I understand you are currently enrolled in a Cardiology clinical trial (a research study). 
I am conducting a research study to evaluate the informed consent process and your 
understanding of the information presented to you. By completing the information on the 
demographic form and the survey questions you are consenting to participate in this study.  
 
There is no benefit to you to complete this survey, but I hope the information I receive from this 
study will benefit future research patients. There is no risk to you to complete the survey. Do not 
write your name on the survey. All completed surveys will be anonymous. 
 
This is completely voluntary. If you do not wish to fill out the survey, you do not have to. The 
care you are currently receiving from your physician and the research study you are participating 
in will not be jeopardized by not completing this survey.  
 
Some of the questions may not apply to your clinical trial. Please answer the questions to the best 
of your ability or simply write NA (not applicable) beside the answer. I hope that you and other 
research participants will fill out the survey, so that I may improve the process of informing 
future research participants before they agree to participate in a clinical trial. 
 
Completion of the survey means that you are 18 years of age or older and have given your 
consent to participate in this study. 
 
If you have any questions about this research project, or the survey, please email me at 
djpalmer@uwm.edu. Thank you for your time. 
 
Sincerely: 
Debra Gillespie, RN, MS 
Principle Investigator 
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APPENDIX D 
 
Demographic Information Sheet 
 
Age: __________ 
 
Gender: Male ___     Female ___ 
 
Have you ever been a subject in clinical research before enrolling in your oncology study? 
Yes ___   No ___ 
 
Approximate household income per year: 
 
Less than $25,000 per year ___ 
$25,001- $50,000 ___ 
$50,001- $75,000 ___ 
$75,001- $100,000 ___ 
More than $100,000 ___ 
 
What is the highest level of education you have completed? 
0-8 years ___ 
9-12 years (high school graduation) ___ 
High School Diploma/GED (no college) ___ 
1-2 years of college ___ 
4 years of college ___ 
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APPENDIX E 
Quality of Informed Consent 
SECTION A:  Below you will find several statements about clinical trials (otherwise known as 
research studies).  Thinking about your clinical trial, please read each statement carefully. Then 
tell us whether you agree with the statement, you disagree with the statement, or you are unsure 
about the statement by circling the appropriate response.  Please respond to each statement as 
best you can.  We are interested in your opinions. 
     
A1. When I signed the consent form for my current 
cardiology therapy, I knew that I was agreeing to 
participate in a clinical trial. 
Disagree1 Unsure2 Agree3 
A2. The main reason cardiology clinical trials are 
done is to improve the treatment of future 
cardiology patients. 
Disagree1 Unsure2 Agree3 
A3. I have been informed how long my participation 
in this clinical trial is likely to last. 
Disagree1 Unsure2 Agree3 
A4. All the treatments and procedures in my clinical 
trial are standard for my type of cardiac disease. 
Disagree1 Unsure2 Agree3 
A5. In my clinical trial, one of the researchers’ major 
purposes is to compare the effects (good and bad) 
of two or more different ways of treating patients 
with my type of cardiac disease, in order to see 
which is better. 
Disagree1 Unsure2 Agree3 
A6. In my clinical trial, one of the researchers’ major 
purposes is to test the safety of a new drug or 
treatment. 
Disagree1 Unsure2 Agree3 
A7. In my clinical trial, one of the researchers’ major 
purposes is to find the highest dose of a new drug 
or treatment that can be given without causing 
severe side effects. 
Disagree1 Unsure2 Agree3 
A8. In my clinical trial, one of the researchers’ major 
purposes is to find out what effects (good and 
bad) a new treatment has on me and my cardiac 
disease. 
Disagree1 Unsure2 Agree3 
A9. The treatment being researched in my clinical 
trial has been proven to be the best treatment for 
my type of cardiac disease. 
Disagree1 Unsure2 Agree3 
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A10. In my clinical trial, each group of patients 
receives a higher dose of the treatment than the 
group before, until some patients have serious 
side effects. 
Disagree1 Unsure2 Agree3 
A11. After I agreed to participate in my clinical trial, 
my treatment was chosen randomly (by chance) 
from two or more possibilities. 
Disagree1 Unsure2 Agree3 
A12. Compared with standard treatments for my type 
of cardiac disease my clinical trial does not carry 
any additional risks or discomforts. 
Disagree1 Unsure2 Agree3 
A13. There may not be direct medical benefit to me 
from my participation in this clinical trial. 
Disagree1 Unsure2 Agree3 
A14. By participating in this clinical trial, I am helping 
the researchers learn information that may benefit 
future cardiac patients. 
Disagree1 Unsure2 Agree3 
A15. Because I am participating in a clinical trial, it is 
possible that the study sponsor, various 
government agencies, or others who are not 
directly involved in my care could review my 
medical records. 
Disagree1 Unsure2 Agree3 
A16. My doctors did not offer me any alternatives 
besides treatment in this clinical trial. 
Disagree1 Unsure2 Agree3 
A17. The consent form I signed describes who will pay 
for treatment if I am injured or become ill as a 
result of participation in this clinical trial. 
Disagree1 Unsure2 Agree3 
A18. The consent form I signed lists the name of the 
person (or persons) whom I should contact if I 
have any questions or concerns about the clinical 
trial. 
Disagree1 Unsure2 Agree3 
A19. If I had not wanted to participate in this clinical 
trial, I could have declined to sign the consent 
form. 
Disagree1 Unsure2 Agree3 
A20. I will have to remain in the clinical trial even if I 
decide someday that I want to withdraw. 
Disagree1 Unsure2 Agree3 
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SECTION B:  When you signed the consent form to participate in your clinical trial, how well 
did you understand the following aspects of your clinical trial?  If you didn’t understand the item 
at all, please circle 1.  If you understood it very well, please circle 5.  If you understand it 
somewhat, please circle a number between 1 and 5. 
  I Didn’t 
Understand 
This at All 
 
I Understood 
This Very 
Well 
B1. The fact that your treatment involves research 
1 2 3 4 5 
B2. What the researchers are trying to find out in 
the clinical trial 
1 2 3 4 5 
B3. How long you will be in the clinical trial 
1 2 3 4 5 
B4. The treatments and procedures you will 
undergo 
1 2 3 4 5 
B5. Which of these treatments and procedures are 
experimental 
1 2 3 4 5 
B6. The possible risks and discomforts of 
participating in the clinical trial 
1 2 3 4 5 
B7. The possible benefits to you of participating in 
the clinical trial 
1 2 3 4 5 
B8. How your participation in this clinical trial may 
benefit future patients 
1 2 3 4 5 
B9. The alternatives to participation in the clinical 
trial 1 2 3 4 5 
B10. The effect of the clinical trial on the 
confidentiality of your medical records 1 2 3 4 5 
B11. Who will pay for treatment if you are injured or 
become ill because of participation in this 
clinical trial 
1 2 3 4 5 
B12. Whom you should contact if you have questions 
or concerns about the clinical trial 1 2 3 4 5 
B13. The fact that participation in the clinical trial is 
voluntary 1 2 3 4 5 
B14. Overall, how well did you understand your 
clinical trial when you signed the consent form? 1 2 3 4 5 
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APPENDIX F 
 
 
Reminder Postcard 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Front of Postcard 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Back of Postcard 
 
 
 
 
 
 
 
 
Date  
 
This is a friendly reminder to complete the 
Quality of Informed Consent survey that was 
recently mailed to you. Place the completed 
survey in the stamped returned envelope provided 
to you. If you have already completed the survey, 
thank you.  
Debra Gillespie 
 
 
Name 
Address 
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APPENDIX G 
 
Teach Back Educational Presentation 
 
Slide 1 
Understanding the Basic Principles
of Teach Back
Debra Gillespie RN, MS
Doctoral Candidate
University of Wisconsin, Milwaukee
May 2016
 
 
Slide 2 
Purpose
The purpose of this activity is to discuss miscommunication and its 
impact on patients and to strategize methods using teach back to 
improve communication
Declarations
No conflict of interest has been identified for this program.
There is no commercial support for today’s program.
In order to receive contact hours please sign the roster, complete 
the evaluation, and attend the entire program.
This continuing nursing education activity was approved by the Northeast 
Multi-State Division (NE-MSD), an accredited approver by the American Nurses 
Credentialing Center’s Commission on Accreditation.
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Slide 3 
Objectives
 List 3 patient problems caused by miscommunication
 Describe one model used to describe teach back
 Demonstrate teach back communication during role play 
 
 
Slide 4 
Health Literacy
“The degree to which individuals have the capacity to obtain, process, 
and understand basic health information and services needed to make 
appropriate health decisions”
Institute of Medicine (2004). 
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Slide 5 
Background
 Ninety million adult Americans have basic or below basic health literacy (reading 
level 1 or 2) National Adult Literacy Survey (NALS) 
 Maine has 400,000 adults (42% of the adult population) functioning at reading 
Level 1 and 2
Level 1: defined as having difficulty finding information in unfamiliar or 
complex texts such as newspaper articles, medicine labels, forms, charts 
This is an adult who can not read well enough to fill out an
application, understand a food label, or read a story to a child. (15% of Maine's 
adults function at this level)
Level 2: can identify key pieces of information and perform simple calculations 
such as those on an order form (27% of Maine's adults function at this level) 
 
 
Slide 6 
Additionally....
 40-80% of medical information is forgotten almost immediately with the 
greater the information being given proportional to the amount of 
information forgotten (Kessels, R. (2003). 
 Low health literacy costs the U.S. economy $106-238 billion dollars 
annually (Friedland, R., 2002). 
 Studies demonstrate causal relationships between poor health literacy 
and poor health outcomes such as increased hospitalizations, increased 
use of the ED, and increase in medication errors
 Patients are often readmitted due to adverse event related to 
 Lack of understanding of discharge instructions
 Not sure of what danger signs to watch out for
 Not sure about follow up tests and procedures
 Not sure of exact medication regimen
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Slide 7 
Background in Research Participants
 There is a body of knowledge demonstrating that research participants 
have significant misunderstandings about the potential benefits, risks 
and other aspects of their research study 
 As many as 25-60% of research participants are unable to recall or 
understand important information during the research consenting 
process (Aaronson, et al., 1996; McCarthy et al., 2012)
 Research has also shown that patients think they understand even 
when they don’t
 
 
Slide 8 
What is Teach Back?
 Asking patients to repeat back in their own words what you have 
explained to them
 Not a test of the patient, but of how well you explained a concept
 A chance to check for understanding and, if necessary, re-teach the 
information
 It’s a way of speaking & writing that helps people to
 Discover what they need 
 Understand what they have been told 
 Act appropriately on that understanding
Teach back is not about dumbing things down 
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Slide 9 
Examples of Plain, Non-Medical Language
Instead of this Say this
Benign Not cancer
Fracture Broken bone
Inhaler Puffer
Hypertension High blood pressure
Oral By mouth
Ambulate Walk
Optimal Best way
 
 
Slide 10 
Use Language the Patient will Understand
─ Avoid Acronyms
 instead of “HDL”, explain “good cholesterol”
─ Avoid Abbreviations and Technical Terms
 instead of “anti-hypertensive”, explain “drugs that help to lower 
blood pressure”
─ Be Specific and Clear
 instead of “don’t go crazy with salt”, explain “keep your salt intake 
to x mg per day”
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Slide 11 
Goals of Teach Back
 Empower the patient to be able to make an informed decision
 Check for understanding and correct any misunderstandings
 Avoid rushing the patient
 Provide education when the patient is not hurried, anxious, bewildered, 
passive, or distracted
 Present factual information rather than a personal interpretation
 
 
Slide 12 
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Slide 13 
Teach Back Demonstration
 Please click on the link below to watch a demonstration 
 http://youtu.be/IKxjmpD7vfY 
 
 
Slide 14 
Questions to Establish Rapport
 “I’d like to be certain I have explained the risks of your clinical trial. 
Can you tell me what the potential risks of this study are should you 
decide to enroll?”
 “If you enroll into this study, you will be randomized to receive one of 
two different treatments. Can you tell me what is meant by 
randomized?”
 “Tell me what you heard me say about the benefits to you if you enroll 
into this study.” 
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Slide 15 
Teach Back Scripts
 “I want to make sure I explained everything clearly. If you were trying 
to explain about this clinical trial, what would you say?”
 “Let’s review the main risks of this study. What are some things that I 
mentioned were possible risks?”
 
 
 
Slide 16 
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APPENDIX H 
 
Understanding the Basic Principles of Teach Back-Quiz 
 
Please answer the following questions by circling the correct response. 
 
1. Approximately how many Americans are said to struggle with health literacy? 
 
A. 200,000 
B. 1 million 
C. 90 million 
D. 42 million 
 
2. Patients with limited health literacy are more likely to be re-admitted to the hospital 
due in part to which of the following? 
 
A. Not understanding how and when to take their medications 
B. Not clear on when they may have follow up appointments and tests 
C. Not understanding their hospital discharge instructions 
D. All of the above 
 
3. According to research, approximately how many research participants do not 
understand their clinical trial? 
 
A. Up to 10 percent 
B. Between 25-60 percent 
C. Between 70-80 percent 
D. Between 80-90 percent 
 
4. Some key concepts to discuss when consenting a patient for a clinical trial include 
(circle all that apply) 
 
A. The investigator’s name and phone number 
B. The potential risks to the subject 
C. The voluntary nature of research participation 
D. How research is no different than their standard care 
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5. Techniques to improve health literacy include (circle all that apply) 
 
A. The patient repeats back to you in their own words what you have told them 
B. If a patient nods “yes” in agreement, this indicates they understand you 
C. Using plain language instead of medical jargon 
D. Using simple yes/no questions to avoid confusing the patient 
 
6. Communication theory may support clinicians to practice the use of teach back. 
What specific communication model guides this practice? 
 
A. The Baxter Method of Communication 
B. The Berlo Communication Theory 
C. The Sherman Communication Theory 
D. The Shannon-Weaver Communication Theory 
 
7. Patients who are only able to read at reading level 1 would have difficulties reading 
the following: 
 
A. A newspaper 
B. A children’s book 
C. A job application 
D. A and C only 
E. All of the above 
 
8. Studies have shown a causal relationship with poor health literacy and which of the 
following (circle all that apply) 
 
A. An increase in hospitalizations 
B. An increase in falls among the elderly 
C. An increase in trips to the Primary Care Physicians 
D. An increase in medication errors 
 
9. Some examples of replacing medical jargon with plain language would include 
(circle all that apply) 
 
A. Saying “hypertension” rather than “high blood pressure” 
B. Saying “broken bone” rather than “fracture” 
C. Saying “not cancer” rather than “benign” 
D. Saying “ambulate” rather than “walk” 
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10. Teach back is (circle all that apply) 
 
A. A way to capture the patient’s attention 
B. A way to check for patient understanding 
C. A method used to dumb down information to patients 
D. A measure of how well you have explained something to the patient 
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